| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size (ml) | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 5.3.1 | Magnesium Sulphate Injection 500mg/ml | Emcure Pharmaceuticals | Maginsta | Magnesium Sulphate Injection 500mg/ml | Injection | 2 | 12.40 | 801000 | 8.69% | 6.20 | -- |
| -- | 5.3.1 | Magnesium Sulphate Injection 500mg/ml | Neon Laboratories | Magneon-10ml | Magnesium Sulphate Injection 50% w/v | Ampoule | 10 | 26.40 | 413000 | 4.48% | 2.64 | -- |
| -- | 5.3.1 | Magnesium Sulphate Injection 500mg/ml | Neon Laboratories | Magneon-2ml | Magnesium Sulphate Injection 50% w/v | Ampoule | 2 | 8.00 | 8002000 | 86.83% | 4.00 | -- |
-- |
9216000 | 100% | 4.28 | 4.96 | ||||||||
-- |
Maximum | 6.20 | Minimum | 2.64 | ||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
92.16 | (Rs. In Lakhs) | -- |
|||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
12.84 | -- |
||||||||
-- |
Number of Packs considered | -- |
3 | -- |
||||||||
-- |
Ceiling Price | -- |
4.28 | -- |
||||||||
-- |
Add : 16% Retailer Margin | -- |
0.68 | -- |
||||||||
-- |
MRP (without local taxes) | -- |
4.96 | -- |
||||||||
-- |
% Reduction with compared to Highest Price | -- |
30.97% | -- |
||||||||
-- |
S.O. 3328(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 5.5.3 | Phenytoin Sodium Injection 50mg/ml | Zydus Cadila Healthcare | Epsolin Inj. | Phenytoin Sodium Injection 50mg/ml | Amp. | 2 | ml | 9.31 | 38835315 | 51.31% | 4.66 | -- |
| -- | 5.5.3 | Phenytoin Sodium Injection 50mg/ml | Pfizer | Dilantin Inj. | Phenytoin Sodium Injection 50mg/ml | Amp. | 2 | ml | 9.92 | 2857264.9 | 3.77% | 4.96 | -- |
| -- | 5.5.3 | Phenytoin Sodium Injection 50mg/ml | Abbott Healthcare Pvt. Ltd. | Eptoin | Phenytoin Sodium Injection 50mg/ml | Amp. | 2 | ml | 8.78 | 28000000 | 36.99% | 4.39 | -- |
| -- | 5.5.3 | Phenytoin Sodium Injection 50mg/ml | MANKIND | EPTOKIND | Phenytoin Sodium Injection 50mg/ml | Ampoules | 2 | ML | 8.91 | 2599813 | 3.43% | 4.46 | -- |
| -- | 5.5.3 | Phenytoin Sodium Injection 50mg/ml | ALKEM* | PHENYKEM | Phenytoin Sodium Injection 50mg/ml | Ampoules | 2 | ML | 8.46 | 1693258 | 2.24% | 4.23 | -- |
| -- | 5.5.3 | Phenytoin Sodium Injection 50mg/ml | INTAS PHARMA* | CELETOIN | Phenytoin Sodium Injection 50mg/ml | Ampoules | 2 | ML | 7.83 | 1126937 | 1.49% | 3.92 | -- |
| -- | 5.5.3 | Phenytoin Sodium Injection 50mg/ml | MOLEKULE INDIA | PHALIN | Phenytoin Sodium Injection 50mg/ml | Ampoules | 2 | ML | 8.99 | 425381 | 0.56% | 4.50 | -- |
| -- | 5.5.3 | Phenytoin Sodium Injection 50mg/ml | SAMARTH PHARMA | PHENYTOIN | Phenytoin Sodium Injection 50mg/ml | Ampoules | 2 | ML | 41.68 | 151591 | 0.20% | 20.84 | -- |
-- |
75689560 | 100% | 4.44 | 5.15 | |||||||||
-- |
Maximum | 4.96 | Minimum | 3.92 | |||||||||
-- |
As per the above there are 6 companies consisting of Market Share of 1% & Above | -- |
|||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
751.13 | (Rs. In Lakhs) | -- |
||||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
26.62 | -- |
|||||||||
-- |
Number of Packs considered | -- |
6 | -- |
|||||||||
-- |
Ceiling Price | -- |
4.44 | -- |
|||||||||
-- |
Add : 16% Retailer Margin | -- |
0.71 | -- |
|||||||||
-- |
MRP (without local taxes) | -- |
5.15 | -- |
|||||||||
-- |
% Reduction with compared to Highest Price | -- |
10.48% | -- |
|||||||||
-- |
S.O. 3329(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 6.3.2.1 | Clotrimazole Pessaries 100 mg | SUN* | CANSOFT | CANSOFT SUPP 100 MG x 6 | SUPPOSITORIES | 6 | SUPPOSITORIES | 46.20 | 6165326 | 9.21% | 7.70 | -- |
| -- | 6.3.2.1 | Clotrimazole Pessaries 100 mg | GLENMARK | CANDID | CANDID V6 SUPP VAG. 100 MG x 6 | SUPPOSITORIES | 6 | SUPPOSITORIES | 52.95 | 52644000 | 78.63% | 8.83 | -- |
| -- | 6.3.2.1 | Clotrimazole Pessaries 100 mg | BAYER ZYDUS PHARMA | CANESTEN | CANESTEN SUPP VAG. 100 MG x 6 | SUPPOSITORIES | 6 | SUPPOSITORIES | 32.22 | 7548538 | 11.27% | 5.37 | -- |
| -- | 6.3.2.1 | Clotrimazole Pessaries 100 mg | MERIDIAN LAB | CLOSUPP | CLOSUPP SUPP VAG. 100 MG x 6 | SUPPOSITORIES | 6 | SUPPOSITORIES | 21.33 | 128 | 0.00% | 3.56 | -- |
| -- | 6.3.2.1 | Clotrimazole Pessaries 100 mg | AGIO PHARMACEUTICALS | N.A. | CLOTRIMAZOLE SUPP VAG. 100 MG x 6 | SUPPOSITORIES | 6 | SUPPOSITORIES | 20.57 | 104256 | 0.16% | 3.43 | -- |
| -- | 6.3.2.1 | Clotrimazole Pessaries 100 mg | TORQUE PHARMACEUTICALS | FUNGNIL- V | FUNGNIL-V SUPP VAG. 100 MG x 6 | SUPPOSITORIES | 6 | SUPPOSITORIES | 10.00 | 492900 | 0.74% | 1.67 | 8.47 |
-- |
-- | 66955148 | 100.00% | 7.30 | -- | ||||||||
-- |
Maximum | 8.83 | Minimum | 5.37 | -- | ||||||||
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
|||||||||||
-- |
Sum of total MAT considered for price calculation | -- | -- | -- | 663.58 | (Rs. In Lakhs) | -- |
||||||
-- |
Sum of total value of PTR considered for price calculation | -- |
21.90 | -- |
|||||||||
-- |
Number of Packs considered | -- |
3.00 | -- |
|||||||||
-- |
Average Price | -- |
7.30 | -- |
|||||||||
-- |
Add : 16% Retailer Margin | -- |
1.17 | -- |
|||||||||
-- |
MRP (without local taxes) | -- |
8.47 | -- |
|||||||||
-- |
% Reduction as compared to Highest Price | -- |
17.30% | -- |
|||||||||
-- |
S.O. 3330(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 6.4.1.1.4 | Acyclovir Injection 500 mg | SAMARTH PHARMA | AXOVIR | AXOVIR INJ DRY VIAL 500 MG x 1 | Infusion | 1 | Infusion | 349.71 | ######### | 91.66% | 349.71 | -- |
| -- | 6.4.1.1.4 | Acyclovir Injection 500 mg | VHB LIFESCIENCES | ZOYLEX | ZOYLEX INJ LYO VIAL 500 MG 10 ML x 1 | Infusion | 1 | vial | 353.16 | 258160.00 | 3.57% | 353.16 | -- |
| -- | 6.4.1.1.4 | Acyclovir Injection 500 mg | NEISS LABS LTD | NISIVIR | NISIVIR I.V. 500 MG x 1 | Infusion | 1 | -- | 419.05 | 345050.00 | 4.77% | 419.05 | -- |
| -- | -- | -- |
######### | 100.00% | 373.97 | 433.81 | |||||||
-- |
maximum | 419.05 | minimum | 349.71 | |||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
|||||||||||
-- |
Sum of total MAT considered for price calculation | -- |
72.33 | (Rs. In Lakhs) | -- |
||||||||
-- |
Sum of total value of PTR considered for price calculation | -- |
1121.92 | -- |
|||||||||
-- |
Number of Packs considered | -- |
3.00 | -- |
|||||||||
-- |
Ceiling Price | -- |
373.97 | -- |
|||||||||
-- |
Add : 16% Retailer Margin | -- |
59.84 | -- |
|||||||||
-- |
MRP (without local taxes) | -- |
433.81 | -- |
|||||||||
-- |
% Reduction as compared to Highest Price | -- |
10.76% | -- |
|||||||||
-- |
S.O. 3331(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 6.5.3.1.7.2 | Clindamycin Tablet 300 mg | NEXUS BIOTECH | TAB CLIND | TAB CLIND 300 MG*10 *10 | Tablets | 10 | Per Tabs | 127.2 | 636000.00 | 27.08% | 12.72 | -- |
| -- | 6.5.3.1.7.2 | Clindamycin Tablet 300 mg | INDI PHARMA | CLINCIN | CLINCIN TABS 300 MG x 10 | Tablets | 10 | Per Tabs | 98.47 | ######### | 72.92% | 9.85 | -- |
-- |
######### | 100.00% | 11.28 | 13.09 | |||||||||
-- |
maximum | 12.72 | minimum | 9.85 | -- | ||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
|||||||||||
-- |
Sum of total MAT considered for price calculation | -- | -- | -- | 23.49 | (Rs. In Lakhs) | -- |
||||||
-- |
Sum of total value of PTR considered for price calculation | -- |
22.57 | -- |
|||||||||
-- |
Number of Packs considered | -- |
2.00 | -- |
|||||||||
-- |
Average Price | -- |
11.28 | -- |
|||||||||
-- |
Add : 16% Retailer Margin | -- |
1.81 | -- |
|||||||||
-- |
MRP (without local taxes) | -- |
13.09 | -- |
|||||||||
-- |
% Reduction as compared to Highest Price | -- |
11.29% | -- |
|||||||||
-- |
S.O. 3332(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.1.2.3.1. | Cyclosporine Concentrate for Injection 100 mg/ml | RPG LIFESCIENCES | ARPIMUNE LIQUID | BOTTLE | 50ML | 2982.2 | 800000.00 | 2.61% | 59.64 | -- |
| -- | 8.1.2.3.1. | Cyclosporine Concentrate for Injection 100 mg/ml | NOVARTIS | NEORAL | BOTTLE | 50ML | 7245 | ########## | 97.39% | 144.90 | -- |
-- |
########## | 100.00% | 102.27 | 118.64 | |||||||
-- |
Maximum | 144.9 | Minimum | 59.6438 | -- | ||||||
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
|||||||||
-- |
Sum of total MAT considered for price calculation | -- | -- | -- | 305.97 | (Rs. In Lakhs) | -- |
||||
-- |
Sum of total value of PTR considered for price calculation | -- |
204.54 | -- |
|||||||
-- |
Number of Packs considered | -- |
2.00 | -- |
|||||||
-- |
Average Price | -- |
102.27 | -- |
|||||||
-- |
Add : 16% Retailer Margin | -- |
16.36 | -- |
|||||||
-- |
MRP (without local taxes) | -- |
118.64 | -- |
|||||||
-- |
% Reduction as compared to Highest Price | -- |
29.42% | -- |
|||||||
-- |
S.O. 3333(E) dated 05.11.2013 | -- |
|||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Type | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per pack | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.2.15.1 | L-Asparaginase Inj 5000 KU | Biochem | Leunase | -- | inj | 1 | 1279.24 | 36154666.00 | 94.24% | 1279.24 | -- |
| -- | 8.2.15.1 | L-Asparaginase Inj 5000 KU | Dr Reddy’s | L-Asparaginase Inj 5000 IU | -- | inj | 1 | 762 | 2000000.00 | 5.21% | 762.00 | -- |
| -- | 8.2.15.1 | L-Asparaginase Inj 5000 KU | Miracalus | L-Aspase | vial | inj | 1 | 769 | 208485.00 | 0.54% | 769.00 | -- |
-- |
Total | -- |
38363151.00 | 100.00% | 2810.24 | 1183.92 | ||||||
-- |
Average | -- | 1020.62 | -- | ||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
381.55 | (Rs. In Lakhs) | -- |
|||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
2041.24 | -- |
||||||||
-- |
Number of Packs considered | -- |
2.00 | -- |
||||||||
-- |
Ceiling Price (Rs.) | -- |
1020.62 | -- |
||||||||
-- |
Add : 16% Retailer Margin | -- |
163.30 | -- |
||||||||
-- |
MRP (without local taxes) (Rs.) | -- |
1183.92 | -- |
||||||||
-- |
% Reduction with compared to Highest Price | -- |
20.22% | -- |
||||||||
-- |
S.O. 3334(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.2.16.1 | Melphalan Tablets 2mg | Celon Laboratories Ltd. | Alkacel 2mg | Alkacel 2mg Tab | Tablet | 25 | 2209.52 | 20614722 | 93.56% | 88.38 | -- |
| -- | 8.2.16.1 | Melphalan Tablets 2mg | Natco Pharma Ltd. | Alphalan 2 mg | Alphalan 2 mg Tab | Tablet | 25 | 2468.57 | 1419825 | 6.44% | 98.74 | -- |
-- |
Total | -- |
22034547 | 100.00% | 187.12 | 93.56 | ||||||
-- |
Average | -- | 93.56 | 108.53 | ||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
220.35 | (Rs. In Lakhs) | -- |
|||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
187.12 | -- |
||||||||
-- |
Number of Packs considered | -- |
2 | -- |
||||||||
-- |
Ceiling Price (Rs.) | -- |
93.5618 | -- |
||||||||
-- |
Add : 16% Retailer Margin | -- |
14.97 | -- |
||||||||
-- |
MRP (without local taxes) (Rs.) | -- |
108.53 | -- |
||||||||
-- |
% Reduction with compared to Highest Price | -- |
5.25% | -- |
||||||||
-- |
S.O. 3335(E) dated 05.11.2013 | -- |
||||||||||
-- |
PRICING OF NLEM DRUGS | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.2.16.2 | Melphalan Tablets 5mg | Celon Laboratories Ltd. | Alkacel 5mg | Alkacel 5mg Tab | Tablet | 25 | 3733.33 | 24046753 | 84.31% | 149.33 | -- |
| -- | 8.2.16.2 | Melphalan Tablets 5mg | Natco Pharma Ltd. | Alphalan 5 mg | Alphalan 5 mg Tab | Tablet | 25 | 4114.29 | 4473839.86 | 15.69% | 164.57 | -- |
-- |
Total | -- |
28520592.9 | 100.00% | 313.90 | 156.95 | ||||||
-- |
Average | -- | 156.95 | 182.06 | ||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
285.21 | (Rs. In Lakhs) | -- |
|||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
313.90 | -- |
||||||||
-- |
Number of Packs considered | -- |
2 | -- |
||||||||
-- |
Ceiling Price (Rs.) | -- |
156.95 | -- |
||||||||
-- |
Add : 16% Retailer Margin | -- |
25.11 | -- |
||||||||
-- |
MRP (without local taxes) (Rs.) | -- |
182.06 | -- | -- |
|||||||
-- |
% Reduction with compared to Highest Price | -- |
4.63% | -- |
||||||||
-- |
S.O. 3336(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Type | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per tab | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.2.17.1 | Mercaptopurine 50 mg | Zydus Cadila | 6MP50 Tab | -- | Tablet | 10 | 53.1 | 6852658 | 95.50% | 5.31 | -- |
| -- | 8.2.17.1 | Mercaptopurine 50 mg | Miraculus | Purinetone | -- | Tablet | 100 | 1142.86 | 140699 | 1.96% | 11.43 | -- |
| -- | 8.2.17.1 | Mercaptopurine 50 mg | VHB Life Science Ltd. | Puricor | -- | Tablet | 100 | 636 | 116000 | 1.62% | 6.36 | -- |
| -- | 8.2.17.1 | Mercaptopurine 50 mg | Neon Laboratories Ltd. | Captomer | -- | Tablet | 10 | 67 | 66000 | 0.92% | 6.70 | -- |
-- |
Total | -- |
7175357 | 100.00% | 29.80 | 8.93 | ||||||
-- |
Average | -- | 7.70 | -- | ||||||||
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
71.09 | (Rs. In Lakhs) | -- |
|||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
23.10 | -- |
||||||||
-- |
Number of Packs considered | -- |
3 | -- |
||||||||
-- |
Ceiling Price (Rs.) | -- |
7.70 | -- |
||||||||
-- |
Add : 16% Retailer Margin | -- |
1.23 | -- |
||||||||
-- |
MRP (without local taxes) (Rs.) | -- |
8.93 | -- |
||||||||
-- |
% Reduction with compared to Highest Price | -- |
32.63% | -- |
||||||||
-- |
S.O. 3337(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size (ML) | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per ml |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | BMS india Pvt Ltd | Taxol 30 mg | Vial | Injection | 5 | 2600.00 | 21376557 | 32.20% | 520.00 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Dr.Reddy’s | Mitotax | Vial | Injection | 5 | 1348.20 | 17000000 | 25.61% | 269.64 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Fresenius Kabi | Intaxel | Vial | Injection | 5 | 1276.19 | 4509377 | 6.79% | 255.24 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Celon Labs | Celtax | Vial | Injection | 5 | 1120.00 | 3868312 | 5.83% | 224.00 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Alkem Lab | Altaxelnova 30 | Vial | Injection | 5 | 1620.87 | 2000000 | 3.01% | 324.17 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Alkem Lab | Altaxelnova 300 | Vial | Injection | 50 | 8447.68 | 500000 | 0.75% | 168.95 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Alkem Lab | Altaxelnova 100 | Vial | Injection | 16.67 | 4240.13 | 1800000 | 2.71% | 254.36 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Alkem Lab | Altaxelnova 260 | Vial | Injection | 43.34 | 8368.32 | 500000 | 0.75% | 193.09 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Sun | Oncotaxel-100 | Vial | Injection | 17 | 2511.24 | 1752000 | 2.64% | 147.72 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Sun | Oncotaxel-260 | Vial | Injection | 44 | 5535.24 | 8880000 | 13.38% | 125.80 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | VHB Life Science | Neotaxel | Vial | Injection | 5 | 2000.00 | 994000 | 1.50% | 400.00 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Panaecea Biotech | Paclitrust 30 | Vial | Injection | 5 | 1166.26 | 1215129 | 1.83% | 233.25 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Biochem | Petaxel | vial | Injection | 5 | 1511.47 | 460466 | 0.69% | 302.29 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Hetero Healthcare | Paclitero | Vial | Injection | 5 | 1142.86 | 393269 | 0.59% | 228.57 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Samarth Lifescience | Dutaxel | Vial | Injection | 5 | 1411.05 | 342885.15 | 0.52% | 282.21 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Neon | Taxelon | Vial | Injection | 5 | 555.21 | 260000 | 0.39% | 111.04 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Intas | Cytax30 | Vial | Injection | 5 | 1161.07 | 244733 | 0.37% | 232.21 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Khandelwal | Kansure | Vial | Injection | 5 | 215.09 | 187000 | 0.28% | 43.02 |
| -- | 8.2.20.1 | Paclitaxel Injection 30 mg/5ml | Emcure Pharmaceuticals Ltd | Gros | Vial | Injection | 5 | 1493.97 | 100000 | 0.15% | 298.79 |
-- |
Total | -- |
66383728.2 | 100% | 4614.36 | ||||||
-- |
Average | -- | 259.69 | ||||||||
-- |
As per the above there are 8 companies consisting of Market Share of 1% & Above | -- |
|||||||||
-- |
Sum of MAT value considered for price calculation | -- |
643.95 | (Rs. In Lakhs) | -- |
||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
3116.22 | -- |
|||||||
-- |
Number of Packs considered | -- |
12 | -- |
|||||||
-- |
Ceiling Price (Rs.) | -- |
259.69 | -- |
|||||||
-- |
Add : 16% Retailer Margin | -- |
41.55 | -- |
|||||||
-- |
MRP (without local taxes) (Rs.) | -- |
301.24 | -- |
|||||||
-- |
% Reduction with compared to Highest Price | -- |
50.06% | -- |
|||||||
-- |
S.O. 3338(E) dated 05.11.2013 | -- |
|||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size (ML) | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per ml | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.2.21.1 | Procarbazine Capsules 50 mg | Alkem Laboratories | P-CARZINE | -- | Capsules | 10 | 281.54 | 1100000 | 31.59% | 28.15 | -- |
| -- | 8.2.21.1 | Procarbazine Capsules 50 mg | Neon Laboratories | Hodpro-Cap | -- | Capsules | 10 | 270 | 409000 | 11.75% | 27.00 | -- |
| -- | 8.2.21.1 | Procarbazine Capsules 50 mg | Miraculas Pharma Pvt. Ltd. | Zincocarb | -- | Capsules | 50 | 1333.33 | 1972999 | 56.66% | 26.67 | -- |
-- |
Total | -- |
3481999 | 100.00% | 81.82 | 31.64 | ||||||
-- |
Average | -- | 27.27 | -- | ||||||||
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
34.82 | (Rs. In Lakhs) | -- |
|||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
81.82 | -- |
||||||||
-- |
Number of Packs considered | -- |
3 | -- |
||||||||
-- |
Ceiling Price (Rs.) | -- |
27.27 | -- |
||||||||
-- |
Add : 16% Retailer Margin | -- |
4.36 | -- |
||||||||
-- |
MRP (without local taxes) (Rs.) | -- |
31.64 | -- |
||||||||
-- |
% Reduction with compared to Highest Price | -- |
3.13% | -- |
||||||||
-- |
S.O. 3339(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size (ML) | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per ml | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.2.22.1 | Vinblastine Sulphate Injection 10 mg | Cipla | Cytoblastin | vial | inj | 1 | 165.40 | 2626386 | 82.51% | 165.40 | -- |
| -- | 8.2.22.1 | Vinblastine Sulphate Injection 10 mg | Neon | Inj. Vinblastine | vial | inj | 1 | 400.00 | 405000 | 12.72% | 400.00 | -- |
| -- | 8.2.22.1 | Vinblastine Sulphate Injection 10 mg | Chadra Bhagat Pharma | Chemoblast | vial | inj | 1 | 171.42 | 151535.28 | 4.76% | 171.42 | -- |
-- |
Total | -- |
3182921.28 | 100.00% | 736.82 | 284.90 | ||||||
-- |
Average | -- | 245.61 | -- | ||||||||
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
31.83 | (Rs. In Lakhs) | -- |
|||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
736.82 | -- |
||||||||
-- |
Number of Packs considered | -- |
3 | -- |
||||||||
-- |
Ceiling Price (Rs.) | -- |
245.61 | -- |
||||||||
-- |
Add : 16% Retailer Margin | -- |
39.30 | -- |
||||||||
-- |
MRP (without local taxes) (Rs.) | -- |
284.90 | -- |
||||||||
-- |
% Reduction with compared to Highest Price | -- |
38.60% | -- |
||||||||
-- |
S.O. 3340(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size (ML) | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per ml | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.2.26.1 | Daunorubicin Injection 20 mg Vial | Pfizer | DAUNOMYCIN | vial | inj | 1 | 417.58 | 13260696 | 89.77% | 417.58 | -- |
| -- | 8.2.26.1 | Daunorubicin Injection 20 mg Vial | Chandra Bhagat Pharma Pvt. Ltd | Inj.Daunorubicin | vial | inj | 1 | 297.14 | 1148256.16 | 7.77% | 297.14 | -- |
| -- | 8.2.26.1 | Daunorubicin Injection 20 mg Vial | Neon | DAUNEON | vial | inj | 1 | 200 | 363000 | 2.46% | 200.00 | 914.72 |
-- |
Total | -- |
14771952.2 | 100.00% | 914.72 | 353.69 | ||||||
-- |
Average | -- | 304.91 | -- | ||||||||
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
136.24 | (Rs. In Lakhs) | -- |
|||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
914.72 | -- |
||||||||
-- |
Number of Packs considered | -- |
3 | -- |
||||||||
-- |
Ceiling Price (Rs.) | -- |
304.91 | -- |
||||||||
-- |
Add : 16% Retailer Margin | -- |
48.79 | -- |
||||||||
-- |
MRP (without local taxes) (Rs.) | -- |
353.69 | -- |
||||||||
-- |
% Reduction with compared to Highest Price | -- |
26.98% | -- |
||||||||
-- |
S.O. 3341(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size (ML) | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per ml | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.2.31.1 | Chlorambucil Tablet 2 mg | Celon Labs | Celkeran | -- | Tablet | 30 | 1104.76 | 14862214 | 88.83% | 36.83 | -- |
| -- | 8.2.31.1 | Chlorambucil Tablet 2 mg | Natco Pharma Limited | Clokeran | -- | Tablet | 30 | 1234.29 | 1869000 | 11.17% | 41.14 | -- |
-- |
Total | -- |
16731214 | 100.00% | 77.97 | 45.22 | ||||||
-- |
Average | -- | 38.98 | -- | ||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
167.31 | (Rs. In Lakhs) | -- |
|||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
77.97 | -- |
||||||||
-- |
Number of Packs considered | -- |
2 | -- |
||||||||
-- |
Ceiling Price (Rs.) | -- |
38.98 | -- |
||||||||
-- |
Add : 16% Retailer Margin | -- |
6.24 | -- |
||||||||
-- |
MRP (without local taxes) (Rs.) | -- |
45.22 | -- |
||||||||
-- |
% Reduction with compared to Highest Price | -- |
5.25% | -- |
||||||||
-- |
S.O. 3342(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size (ML) | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per ml | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 10.2.3.1 | Phytomenadione Injection 10 mg/ml | SAMARTH PHARMA | KENADION | -- | inj | 1 | 37.5997812 | 3554961 | 98.87% | 37.60 | -- |
| -- | 10.2.3.1 | Phytomenadione Injection 10 mg/ml | DELVIN FORMULATION | PHYTO-K1 | vial | inj | 1 | 37.950328 | 40493 | 1.13% | 37.95 | -- |
-- |
Total | -- |
3595454 | 100.00% | 75.55 | 43.82 | ||||||
-- |
Average | -- | 37.78 | -- | ||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
35.95 | (Rs. In Lakhs) | -- |
|||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
75.55 | -- |
||||||||
-- |
Number of Packs considered | -- |
2 | -- |
||||||||
-- |
Ceiling Price (Rs.) | -- |
37.78 | -- |
||||||||
-- |
Add : 16% Retailer Margin | -- |
6.04 | -- |
||||||||
-- |
MRP (without local taxes) (Rs.) | -- |
43.82 | -- |
||||||||
-- |
% Reduction with compared to Highest Price | -- |
0.46% | -- |
||||||||
-- |
S.O. 3343(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Type | Dosage Form | Pack Size ml | Price to Retailer (rs.) | MAT Value as on 31st May 2012 (Rs.) | MAT % | Price per ml | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 11.1.4.1 | Dextran 40 injection 10% | Claris Life science | Dextran 40 with NS 10% | Plastic Bottle | inj | 500 | 373.19 | 14082325 | 28.67% | 0.75 | -- |
| -- | 11.1.4.1 | Dextran 40 injection 10% | Claris Life science | Dextran 40 with 5 D | Plastic Bottle | inj | 500 | 251 | 907616 | 1.85% | 0.50 | -- |
| -- | 11.1.4.1 | Dextran 40 injection 10% | Nirma Ltd | Dextran 40 injection (10% w/v) in Sodium Chloride inj | FFS Plastic Bottle | inj | 500 | 351.48 | 14333884 | 29.18% | 0.70 | -- |
| -- | 11.1.4.1 | Dextran 40 injection 10% | Nirma Ltd | Dextran 40 injection (10% w/v) in Dextrose inj | FFS Plastic Bottle | inj | 500 | 351.48 | 3496930.64 | 7.12% | 0.70 | -- |
| -- | 11.1.4.1 | Dextran 40 injection 10% | Sherya Life Science | Rallidex-D | Bottle | inj | 500 | 316.41 | 12657267 | 25.77% | 0.63 | -- |
| -- | 11.1.4.1 | Dextran 40 injection 10% | Sherya Life Science | Rallidex-NS | Bottle | inj | 500 | 316.41 | 3638058 | 7.41% | 0.63 | -- |
-- |
Total | -- |
49116080.7 | 100.00% | 3.92 | 0.76 | ||||||
-- |
Average | -- | 0.65 | -- | ||||||||
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
491.16 | (Rs. In Lakhs) | -- |
|||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
3.92 | -- |
||||||||
-- |
Number of Packs considered | -- |
6 | -- |
||||||||
-- |
Ceiling Price (Rs.) | -- |
0.65 | -- |
||||||||
-- |
Add : 16% Retailer Margin | -- |
0.10 | -- |
||||||||
-- |
MRP (without local taxes) (Rs.) | -- |
0.75 | -- |
||||||||
-- |
% Reduction with compared to Highest Price | -- |
12.47% | -- |
||||||||
-- |
S.O. 3344(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack | Price to Retailer (Rs.) | MAT Value as on 31st May 2012 (Rs.) | MAT % | Price per vial (Rs.) | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 11.2.3.1 | Factor VIII Concentrate Injection Dried | Paviour | Factor VIII SDH | vial | 250 IU inj | 1 | 7340.00 | 12331200 | 9.45% | 7340.00 | -- |
| -- | 11.2.3.1 | Factor VIII Concentrate Injection Dried | Baxter | Hemofilm | vial | 250 IU inj | 1 | 3143.50 | 118138150 | 90.55% | 3143.50 | -- |
-- |
Total | -- |
130469350 | 100.00% | 10483.50 | 6080.43 | ||||||
-- |
Average | -- | 5241.75 | -- | ||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
1304.69 | (Rs. In Lakhs) | -- |
|||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
10483.50 | -- |
||||||||
-- |
Number of Packs considered | -- |
2 | -- |
||||||||
-- |
Ceiling Price (Rs.) | -- |
5241.75 | -- |
||||||||
-- |
Add : 16% Retailer Margin | -- |
838.68 | -- |
||||||||
-- |
MRP (without local taxes) (Rs.) | -- |
6080.43 | -- |
||||||||
-- |
% Reduction with compared to Highest Price | -- |
28.59% | -- |
||||||||
-- |
S.O. 3345(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique no. as per NLEM | Composition as per NLEM | Company | Brand | Pack size | Price to Retailer | MAT Value | MAT % | Price per unit |
|---|---|---|---|---|---|---|---|---|---|
| -- | 17.1.2.3 | Omeprazole Capsules 40 mg | U S V | PROTOLOC | 15 | 95.59 | 1E+06 | 63.44% | 6.37 |
| -- | 17.1.2.3 | Omeprazole Capsules 40 mg | Adroit Life Sciences | Elcer 40 | 10 | 59.366 | 152418 | 6.49% | 5.94 |
| -- | 17.1.2.3 | Omeprazole Capsules 40 mg | Taj Pharmaceuticals | Omeprazole Capsules 40 mg | 10 | 35.28 | 705600 | 30.06% | 3.53 |
-- |
2E+06 | 100.00% | 5.28 | ||||||
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
Maximum | 6.37 | Minimum | 3.53 | |||
-- |
Sum of MAT value considered for price calculation | -- |
23.47 | (Rs. in Lakhs) | -- |
||||
-- |
Sum of PTR per unit considered for price calculation | -- |
15.84 | -- |
|||||
-- |
Number of Packs considered | -- |
3 | -- |
|||||
-- |
Ceiling Price | -- |
5.28 | -- |
|||||
-- |
Add : 16% Retailer Margin | -- |
0.84 | -- |
|||||
-- |
MRP (without local taxes) | -- |
6.12 | -- |
|||||
-- |
% Reduction with compared to Highest Price | -- |
17.16% | -- |
|||||
-- |
S.O. 3346(E) dated 05.11.2013 | -- |
|||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Desc. | Dosage Form | Pack Size | Unit | PTR Rs. |
MAT Value as on 31st May 2012 | MAT % | Price per tablet | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 17.4.2.1.1 | Hyoscine Butyl Bromide 10mg | Zydus Healthcare | Buscopan | 10mg | Tablets | 10 | 10’s Strip | 27.84 | 196822763 | 97.46% | 2.78 | -- |
| -- | 17.4.2.1.1 | Hyoscine Butyl Bromide 10mg | Inga Laboratories P. Ltd | Belloid | 10mg | Tablets | 10 | 10’s Strip | 20.37 | 1525331 | 0.76% | 2.04 | -- |
| -- | 17.4.2.1.1 | Hyoscine Butyl Bromide 10mg | Ind-Swift | Hyoswift | 10mg | Tablets | 10 | 10’s Strip | 15 | 235125 | 0.12% | 1.50 | -- |
| -- | 17.4.2.1.1 | Hyoscine Butyl Bromide 10mg | Lincoln Pharma | Spaslin-H | 10mg | Tablets | 10 | 10’s Strip | 21.7 | 108695 | 0.05% | 2.17 | -- |
| -- | 17.4.2.1.1 | Hyoscine Butyl Bromide 10mg | Mankind Pharma | Dolokind-SPAS-H | 10mg | Tablets | 10 | 10’s Strip | 26.67 | 54273 | 0.03% | 2.67 | -- |
| -- | 17.4.2.1.1 | Hyoscine Butyl Bromide 10mg | Cipla Ltd. | Hyospan | 10mg | Tablets | 10 | 10’s Strip | 20.95 | 3201912 | 1.59% | 2.10 | -- |
-- |
201948099 | 100.00% | 13.25 | 2.83 | |||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
|||||||||||
-- |
Sum of MAT Value considered for price calculation | -- | 2000.25 | (Rs. in lakh) | -- |
||||||||
-- |
Number of Packs considered | -- | 2 | -- |
|||||||||
-- |
Sum of PTR per unit considered for price calculation | -- | 4.88 | -- |
MAX | 2.784 | MIN | 2.10 | -- | ||||
-- |
Average PTR | -- | 2.44 | -- |
Avg. PTR | 2.44 | -- | ||||||
-- |
Add : 16% Retailer Margin | -- | 0.39 | -- |
|||||||||
-- |
Ceiling Price (without local taxes) | -- | 2.83 | -- |
|||||||||
-- |
% Reduction with compared to highest price | -- | 12.37% | -- |
|||||||||
-- |
S.O. 3347(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brand | Type | Pack Desc. | Size | Pack Size | Unit | PTR Rs. |
MAT Value as on 31st May 2012 | MAT % | Price per Unit (No.) |
Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Extra Dotted | Chocolate | NA | 3 | No. | 15.99 | 43000000 | 3.83% | 5.33 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Extra Dotted | Chocolate | NA | 10 | No. | 48.00 | 25000000 | 2.23% | 4.80 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Extra Dotted | Chocolate | NA | 20 | No. | 96.00 | 1400000 | 0.12% | 4.80 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Extra Dotted | Strawberry | NA | 3 | No. | 15.99 | 46500000 | 4.14% | 5.33 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Extra Dotted | Strawberry | NA | 10 | No. | 48.00 | 25000000 | 2.23% | 4.80 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Extra Dotted | Strawberry | NA | 20 | No. | 96.00 | 1700000 | 0.15% | 4.80 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Extra Dotted | Black Grapes | NA | 3 | No. | 15.99 | 1500000 | 0.13% | 5.33 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Extra Dotted | Black Grapes | NA | 10 | No. | 48.00 | 1900000 | 0.17% | 4.80 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Extra Dotted | Jasmine | NA | 3 | No. | 15.99 | 14100000 | 1.26% | 5.33 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Extra Dotted | Jasmine | NA | 10 | No. | 48.00 | 8600000 | 0.77% | 4.80 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Extra Dotted | Banana | NA | 3 | No. | 15.99 | 31700000 | 2.82% | 5.33 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Extra Dotted | Banana | NA | 10 | No. | 48.00 | 14000000 | 1.25% | 4.80 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | 3 in 1 | Bubblegum | NA | 3 | No. | 15.99 | 29100000 | 2.59% | 5.33 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | 3 in 1 | Bubblegum | NA | 10 | No. | 48.00 | 15000000 | 1.34% | 4.80 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | More | More | NA | 2 | No. | 8.00 | 7400000 | 0.66% | 4.00 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | More | More | NA | 3 | No. | 19.98 | 25300000 | 2.25% | 6.66 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | More | More | NA | 10 | No. | 56.00 | 24000000 | 2.14% | 5.60 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | More | More | NA | 20 | No. | 96.00 | 8300000 | 0.74% | 4.80 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Smooth & Ultrathin | Vanilla | NA | 3 | No. | 15.99 | 9700000 | 0.86% | 5.33 | -- |
| -- | 18.3.3.1 | Condoms | Mankind Pharma Ltd | Manforce | Smooth & Ultrathin | Vanilla | NA | 10 | No. | 48.00 | 4900000 | 0.44% | 4.80 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods 1500 dots | Square | Super Dotted | 53mm | 3 | No. | 33.33 | 4144000 | 0.37% | 11.11 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Aloe Vera | 53mm | 3 | No. | 25.00 | 2400000 | 0.21% | 8.33 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Blaze | Square | Warming Gel | 53mm | 3 | No. | 25.00 | 3350000 | 0.30% | 8.33 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Cool | Square | Cooling Gel | 53mm | 3 | No. | 25.00 | 3726000 | 0.33% | 8.33 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Crezendo | Square | Vibrating Ring | 53mm | 3 | No. | 104.20 | 4847000 | 0.43% | 34.73 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Melange | Square | Assorted | 53mm | 3 | No. | 25.03 | 2763000 | 0.25% | 8.34 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods X’tasy | Square | 3in1&Extra delay | 53mm | 3 | No. | 25.00 | 10224000 | 0.91% | 8.33 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Allnight | Square | Popular | 53mm | 3 | No. | 16.70 | 13209000 | 1.18% | 5.57 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Premium | Square | Allnight (Delay) | 53mm | 3 | No. | 20.80 | 2120000 | 0.19% | 6.93 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Flavoured | 53mm | 3 | No. | 25.00 | 9230000 | 0.82% | 8.33 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Dotted | Square | Strawberry | 53mm | 3 | No. | 25.00 | 2741000 | 0.24% | 8.33 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Scented | 53mm | 3 | No. | 16.67 | 3538000 | 0.32% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Supreme Dotted | 53mm | 3 | No. | 16.67 | 24917000 | 2.22% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Premium Dotted | 53mm | 3 | No. | 20.80 | 6649000 | 0.59% | 6.93 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Supreme Ribbed | 53mm | 3 | No. | 16.70 | 6670000 | 0.59% | 5.57 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Premium Ribbed | 53mm | 3 | No. | 20.85 | 1330000 | 0.12% | 6.95 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Ultrathin | 53mm | 2 | No. | 8.40 | 5654000 | 0.50% | 4.20 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Ultrathin Reg. | 53mm | 3 | No. | 16.67 | 34886000 | 3.11% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Premium | Square | Utrathin | 53mm | 3 | No. | 16.67 | 9559000 | 0.85% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Premium | Square | Allnight | 53mm | 6 | No. | 33.33 | 2142000 | 0.19% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Premium | Square | Supreme Dotted | 53mm | 6 | No. | 33.33 | 2681000 | 0.24% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Premium | Square | Utrathin | 53mm | 6 | No. | 29.17 | 1323000 | 0.12% | 4.86 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Allnight Delay | 53mm | 10 | No. | 50.00 | 12959000 | 1.15% | 5.00 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Supreme Dotted | 53mm | 10 | No. | 50.00 | 33873000 | 3.02% | 5.00 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Ultrathin Reg. | 53mm | 10 | No. | 41.67 | 13914000 | 1.24% | 4.17 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods 1500 dots | Square | Super Dotted | 53mm | 12 | No. | 83.33 | 5938000 | 0.53% | 6.94 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Aloe Vera | 53mm | 12 | No. | 75.00 | 2895000 | 0.26% | 6.25 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Blaze | Square | Warming Gel | 53mm | 12 | No. | 75.00 | 2947000 | 0.26% | 6.25 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Cool | Square | Cooling Gel | 53mm | 12 | No. | 75.00 | 3369000 | 0.30% | 6.25 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Dotted | Square | Strawberry | 53mm | 12 | No. | 66.67 | 474000 | 0.04% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Melange | Square | Assorted | 53mm | 12 | No. | 66.70 | 2928000 | 0.26% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods X’tasy | Square | 3 in 1 | 53mm | 12 | No. | 75.00 | 6108000 | 0.54% | 6.25 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods Premium | Square | Allnight | 53mm | 12 | No. | 54.20 | 5408000 | 0.48% | 4.52 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Flavoured | 53mm | 12 | No. | 75.00 | 2917000 | 0.26% | 6.25 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Premium Dotted | 53mm | 12 | No. | 66.67 | 14613000 | 1.30% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Premium Dotted | 53mm | 12 | No. | 66.67 | 3535000 | 0.31% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Ultrathin Reg. | 53mm | 12 | No. | 50.00 | 15852000 | 1.41% | 4.17 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Variety Pack | 53mm | 16 | No. | 83.30 | 5123000 | 0.46% | 5.21 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Allnight Delay | 53mm | 20 | No. | 100.00 | 4979000 | 0.44% | 5.00 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Super Dotted | 53mm | 20 | No. | 91.67 | 16491000 | 1.47% | 4.58 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods | Square | Ultrathin Reg. | 53mm | 20 | No. | 75.00 | 3870000 | 0.34% | 3.75 | -- |
| -- | 18.3.3.1 | Condoms | Hindustan Latex Ltd | Moods X’tasy | Square | NA | 53mm | 20 | No. | 91.67 | 2593000 | 0.23% | 4.58 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Dotted | 53mm | 3 | No. | 16.67 | 99362589 | 8.85% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Dotted | 53mm | 10 | No. | 50.00 | 77110056 | 6.87% | 5.00 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Dotted | 53mm | 20 | No. | 93.33 | 67209911 | 5.98% | 4.67 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Ribbed | 53mm | 3 | No. | 16.67 | 20244040 | 1.80% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Ribbed | 53mm | 10 | No. | 50.00 | 15691190 | 1.40% | 5.00 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Ribbed | 53mm | 20 | No. | 93.33 | 8340499 | 0.74% | 4.67 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Smooth | 53mm | 3 | No. | 10.00 | 14500800 | 1.29% | 3.33 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Smooth | 53mm | 10 | No. | 33.33 | 5745025 | 0.51% | 3.33 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Smooth | 53mm | 20 | No. | 66.67 | 2376119 | 0.21% | 3.33 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Long Last | 53mm | 3 | No. | 20.00 | 15564240 | 1.39% | 6.67 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Long Last | 53mm | 10 | No. | 60.00 | 27731523 | 2.47% | 6.00 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Long Last | 53mm | 20 | No. | 133.33 | 19550708 | 1.74% | 6.67 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Superthin | 53mm | 3 | No. | 20.00 | 5710032 | 0.51% | 6.67 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Superthin | 53mm | 10 | No. | 60.00 | 11247841 | 1.00% | 6.00 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Superthin | 53mm | 20 | No. | 133.33 | 6743035 | 0.60% | 6.67 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Intensity | 53mm | 10 | No. | 60.00 | 8801279 | 0.78% | 6.00 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Intensity | 53mm | 20 | No. | 133.33 | 5251074 | 0.47% | 6.67 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Wet n Wild | 53mm | 3 | No. | 20.00 | 3029616 | 0.27% | 6.67 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Wet n Wild | 53mm | 10 | No. | 60.00 | 7390803 | 0.66% | 6.00 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Chill Thrill | 53mm | 3 | No. | 20.00 | 7911994 | 0.70% | 6.67 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Chill Thrill | 53mm | 10 | No. | 60.00 | 4914004 | 0.44% | 6.00 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Warm Intimacy | 53mm | 3 | No. | 20.00 | 3168000 | 0.28% | 6.67 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Warm Intimacy | 53mm | 10 | No. | 60.00 | 4204794 | 0.37% | 6.00 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Excite Chocolate | 53mm | 2 | No. | 7.41 | 1024358 | 0.09% | 3.71 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Excite Chocolate | 53mm | 3 | No. | 11.11 | 2543746 | 0.23% | 3.70 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Excite Chocolate | 53mm | 8 | No. | 29.63 | 1088014 | 0.10% | 3.70 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Excite Strawberry | 53mm | 2 | No. | 7.41 | 1168409 | 0.10% | 3.71 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Excite Strawberry | 53mm | 3 | No. | 11.11 | 2303770 | 0.21% | 3.70 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Excite Strawberry | 53mm | 8 | No. | 29.63 | 1408018 | 0.13% | 3.70 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Excite Vanilla | 53mm | 2 | No. | 7.41 | 1120392 | 0.10% | 3.71 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Excite Vanilla | 53mm | 3 | No. | 11.11 | 2255774 | 0.20% | 3.70 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Excite Vanilla | 53mm | 8 | No. | 29.63 | 1168015 | 0.10% | 3.70 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Excite Butterscotch | 53mm | 2 | No. | 7.41 | 976342 | 0.09% | 3.71 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Excite Butterscotch | 53mm | 3 | No. | 11.11 | 2207779 | 0.20% | 3.70 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Excite Butterscotch | 53mm | 8 | No. | 29.63 | 1104014 | 0.10% | 3.70 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Sajan Luxury | 49mm | 2 | No. | 2.76 | 3541190 | 0.32% | 1.38 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Sajan Luxury | 49mm | 2 | No. | 3.57 | 886788 | 0.08% | 1.79 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Contoured | 53mm | 3 | No. | 16.67 | 1259292 | 0.11% | 5.56 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Classic | 53mm | 6 | No. | 22.56 | 195820 | 0.02% | 3.76 | -- |
| -- | 18.3.3.1 | Condoms | JK Ansell Ltd | KamaSutra | NA | Surprise | 53mm | 6 | No. | 22.56 | 105581 | 0.01% | 3.76 | -- |
| -- | 18.3.3.1 | -- |
1123145474 | 100.00% | 576.97 | 6.56 | ||||||||
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
||||||||||||
-- |
Sum of MAT Value considered for price calculation | -- |
11231.45 | (Rs. in lakh) | -- |
|||||||||
-- |
Number of Packs considered | -- |
102 | -- |
||||||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
576.97 | -- |
MAX | 34.73 | MIN | 1.38 | -- | |||||
-- |
Average PTR | -- |
5.66 | -- |
Avg. PTR | 5.66 | -- | |||||||
-- |
Add : 16% Retailer Margin | -- |
0.91 | -- |
||||||||||
-- |
Ceiling Price (without local taxes) | -- |
6.56 | -- |
||||||||||
-- |
% Reduction with compared to highest price | -- |
83.71% | -- |
||||||||||
-- |
S.O. 3348(E) dated 05.11.2013 | -- |
||||||||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Desc. | Dosage Form | Pack Size | Unit | PTR Rs. |
MAT Value as on 31st May 2012 | MAT % | Price per Vial | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 19.2.4.1 | Diphtheria Anti Toxin 10000 IU | Haffkine Biopharmaceutical Corpn | NA | 10ml | Injection | 1 | Vial | 950.00 | 1305300 | 17.60% | 950.00 | -- |
| -- | 19.2.4.1 | Diphtheria Anti Toxin 10000 IU | Vins Bioproducts Ltd. | NA | 10ml | Injection | 1 | Vial | 1043.11 | 6112358 | 82.40% | 1043.11 | -- |
-- |
7417658 | 100.00% | 1993.11 | 1156.00 | |||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
|||||||||||
-- |
Sum of MAT Value considered for price calculation | -- | 74.18 | (Rs. in lakh) | -- |
||||||||
-- |
Number of Packs considered | -- | 2 | -- |
|||||||||
-- |
Sum of PTR per unit considered for price calculation | -- | 1993.11 | -- |
MAX | 1043.11 | MIN | 950 | -- | ||||
-- |
Average PTR | -- | 996.56 | -- |
Avg. PTR | 996.56 | -- | ||||||
-- |
Add : 16% Retailer Margin | -- | 159.45 | -- |
|||||||||
-- |
Ceiling Price (without local taxes) | -- | 1156.00 | -- |
|||||||||
-- |
% Reduction with compared to highest price | -- | 4.46% | -- |
|||||||||
-- |
S.O. 3349(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | PTR Rs. |
MAT Value as on 31st May 2012 | MAT % | Price per Unit (ML) |
Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 19.2.5.1 | Rabies Immunoglobin 150 IU/ml | Bharat Serums and Vaccines Ltd. | Berirab-P | 2ml ampoule | Injection | 2 | ml | 4190.48 | 31495000 | 76.39% | 2095.24 | -- |
| -- | 19.2.5.1 | Rabies Immunoglobin 150 IU/ml | Indian Immunologicals Ltd. | Abhay RIG | 5ml vial | Injection | 5 | ml | 350 | 9736827 | 23.61% | 70.00 | 1255.84 |
-- |
41231827 | 100.00% | 2165.24 | -- | |||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
|||||||||||
-- |
Sum of MAT Value considered for price calculation | -- | 412.32 | (Rs. in lakh) | -- |
||||||||
-- |
Number of Packs considered | -- | 2 | -- |
|||||||||
-- |
Sum of PTR per unit considered for price calculation | -- | 2165.24 | -- |
MAX | 2095.24 | MIN | 70.00 | -- | ||||
-- |
Average PTR | -- | 1082.62 | -- |
-- | Avg. PTR | 1082.62 | -- | |||||
-- |
Add : 16% Retailer Margin | -- | 173.2192 | -- |
|||||||||
-- |
Ceiling Price (without local taxes) | -- | 1255.84 | -- |
|||||||||
-- |
% Reduction with compared to highest price | -- | 48.33% | -- |
|||||||||
-- |
S.O. 3350(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Desc. | Dosage Form | Pack Size ml |
Unit | PTR Rs. |
MAT Value as on 31st May 2012 | MAT % | PTR per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Serum Institute | Genevac-B | 1ml x 1 (Adult) | Inj | 1 | ML | 58.80 | 2432546 | 0.51% | 58.80 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Serum Institute | Genevac-B | 5ml x 1 | Inj | 5 | ML | 272.00 | 3399728 | 0.71% | 54.40 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Serum Institute | Genevac-B | 10ml x 1 (Adult) | Inj | 10 | ML | 534.40 | 92042923 | 19.30% | 53.44 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Serum Institute | Genevac-B | 0.5ml x 1 | Inj | 0.5 | ML | 39.80 | 2648232 | 0.56% | 79.60 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Serum Institute | Genevac-B | 0.5ml x 1 (Pead) | Inj | 0.5 | ML | 40.60 | 8431735 | 1.77% | 81.20 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | GlaxoSmithKline | Engerix B | 1 Dos 1 ml (Adult) | Inj | 1 | ML | 319.63 | 57700000 | 12.10% | 319.63 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | GlaxoSmithKline | Engerix B | 1 Dos 0.5 ml (Paed) | Inj | 0.5 | ML | 199.47 | 64700000 | 13.57% | 398.94 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Sanofi | Shanvac-B | 1 Dos. V. 10 Y 0.5 ml | Inj | 0.5 | ML | 46.15 | 8745333 | 1.83% | 92.30 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Sanofi | Shanvac-B | 1 Dos. V. 20 Y 1 ml x 1 | Inj | 1 | ML | 84.62 | 6776542 | 1.42% | 84.62 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Sanofi | Shanvac-B | 20 Y 10ml x 1 (Mult) | Inj | 10 | ML | 396.19 | 10123050 | 2.12% | 39.62 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Wockhardt Ltd | Biovac-B | IM. Vial 10ml x 1 | Inj | 10 | ML | 560.00 | 13701522 | 2.87% | 56.00 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Bharat Serum | Revac-B | IM. Vial 0.5ml x 1 (Paed) | Inj | 0.5 | ML | 35.00 | 2856564 | 0.60% | 70.00 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Bharat Serum | Revac-B | IM. Vial 10ml x 1 | Inj | 10 | ML | 288.50 | 8944365 | 1.88% | 28.85 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Bharat Biotech | Revac-B | 0.5ml x 1 | Inj | 0.5 | ML | 27.30 | 33797218 | 7.09% | 54.60 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Bharat Biotech | Revac-B | 1ml x 1 | Inj | 1 | ML | 33.60 | 8358656 | 1.75% | 33.60 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Bharat Biotech | Revac-B | 10ml x 1 | Inj | 10 | ML | 103.95 | 32762268 | 6.87% | 10.40 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Bharat Biotech | Revac-B MCF | 0.5ml x 1 | Inj | 0.5 | ML | 89.25 | 7156405 | 1.50% | 178.50 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Indian Immunologicals | Elovac-B | Single dose 0.5ml | Inj | 0.5 | ML | 28.71 | 2204592 | 0.46% | 57.42 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Indian Immunologicals | Elovac-B | Single dose 1ml | Inj | 1 | ML | 39.76 | 743926 | 0.16% | 39.76 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Indian Immunologicals | Elovac-B | Multi Dose 5ml | Inj | 5 | ML | 121.43 | 3279019 | 0.69% | 24.29 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Biological E | Bevac | 1ml | Inj | 1 | ML | 70.72 | 8557537 | 1.79% | 70.72 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Biological E | Bevac | 5ml | Inj | 5 | ML | 357.14 | 91580179 | 19.20% | 71.43 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Biological E | Bevac | 10ml | Inj | 10 | ML | 464.29 | 5960580 | 1.25% | 46.43 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Hindustan Latex | Hivac-B | 0.5 ml x 1 | Inj | 0.5 | ML | 109.00 | 2616 | 0.00% | 218.00 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Hindustan Latex | Hivac-B | 1 ml x 1 | Inj | 1 | ML | 163.50 | 27632 | 0.01% | 163.50 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Hindustan Latex | Hivac-B | 10 ml x 1 | Inj | 10 | ML | 654.00 | 2616 | 0.00% | 65.40 | -- |
| -- | 19.3.1.3.1 | Hepatitis B Vaccine Injection | Unichem | Unihep-B | M.D Vial 10 ml x 1 | Inj | 10 | ML | 325.10 | 23409 | 0.00% | 32.51 | -- |
-- |
476959193 | 100.00% | -- | 101.09 | |||||||||
-- |
As per the above there are 8 companies consisting of Market Share of 1% & Above | -- |
Avg. PTR | 87.15 | -- | ||||||||
-- |
Sum of MAT Value considered for price calculation | -- | 4769.03 | (Rs. in lakh) | -- |
||||||||
-- |
Number of Packs considered | -- | 23 | -- |
|||||||||
-- |
Sum of PTR per unit considered for price calculation | -- | 2004.54 | -- |
MAX | 398.94 | MIN | 10.40 | -- | ||||
-- |
Average PTR | -- | 87.15 | -- |
|||||||||
-- |
Add : 16% Retailer Margin | -- | 13.94 | -- |
|||||||||
-- |
Ceiling Price (without local taxes) | -- | 101.09 | -- |
|||||||||
-- |
% Reduction with compared to highest price | -- | 78.15% | -- |
|||||||||
-- |
S.O. 3351(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | PTR Rs. |
MAT Value as on 31st May 2012 | MAT % | Price per vial | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 19.3.1.4 | Measles Vaccine | Serum Institute of India Ltd | NA | Single dose | Injection | 1 | Vial | 43.04 | 59042000 | 48.63% | 43.04 | -- |
| -- | 19.3.1.4 | Measles Vaccine | GlaxoSmithKline | Priorix | Lyo vial 0.5ml | Injection | 1 | Vial | 393.12 | 62364557 | 51.37% | 393.12 | -- |
-- |
121406557 | 100.00% | 436.16 | 252.97 | |||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
|||||||||||
-- |
Sum of MAT Value considered for price calculation | -- | 1214.07 | (Rs. in lakh) | -- |
||||||||
-- |
Number of Packs considered | -- | 2 | -- |
|||||||||
-- |
Sum of PTR per unit considered for price calculation | -- | 436.16 | -- |
MAX | 393.12 | MIN | 43.04 | -- | ||||
-- |
Average PTR | -- | 218.08 | -- |
Avg. PTR | 218.08 | -- | ||||||
-- |
Add : 16% Retailer Margin | -- | 34.89 | -- |
|||||||||
-- |
Ceiling Price (without local taxes) | -- | 252.97 | -- |
|||||||||
-- |
% Reduction with compared to highest price | -- | 44.53% | -- |
|||||||||
-- |
S.O. 3352(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | PTR Rs. |
MAT Value as on 31st May 2012 | MAT % | Price per vial | Ceiling Price with 16% Margin | – |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 21.1.1.2 | Chloramphenicol Drops 1% | PFIZER | CHLOROMYCETIN | CHLOROMYCETIN APLICAPS 1 % x 50 | OPHTHALMIC OINTMENTS | 50 | Ointment | 42.66 | 61015699 | 94.46% | 0.85 | -- | -- |
| -- | 21.1.1.2 | Chloramphenicol Drops 1% | JAWA | CHLOROCOL | CHLOROCOL EYE OINTMENT 1 % 3 G x 1 | OPHTHALMIC OINTMENTS | 3 | G | 19.47 | 3384791 | 5.24% | 6.49 | -- | -- |
| -- | 21.1.1.2 | Chloramphenicol Drops 1% | ENTOD | OPTICHLOR | OPTICHLOR EYE OINTMENT 1 % 5 G x 1 | OPHTHALMIC OINTMENTS | 5 | G | 18.64 | 192123 | 0.30% | 3.73 | -- | -- |
-- |
64592613 | 100.00% | 3.67 | 4.26 | with 16% Margin | |||||||||
-- |
Maximum | 6.49 | Minimum | 0.85 | -- | |||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
||||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
644.00 | (Rs. In Lakhs) | -- |
|||||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
7.34 | -- |
||||||||||
-- |
Number of Packs considered | -- |
2 | -- |
||||||||||
-- |
Ceiling Price | -- |
3.67 | -- |
||||||||||
-- |
Add : 16% Retailer Margin | -- |
0.59 | -- |
||||||||||
-- |
MRP (without local taxes) | -- |
4.26 | -- |
||||||||||
-- |
% Reduction with compared to Highest Price | -- |
43.43% | -- |
||||||||||
-- |
S.O. 3353(E) dated 05.11.2013 | -- |
||||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 1.1.7.1 | Thiopentone Sodium Injectable 1 g Powder | Neon Labs | Thiosol | Inj. Thiosol Sodium 1gm Vial | Vial | 1 | gm | 45 | 18469000 | 100.00% | 45.00 | -- |
| -- | 1.1.7.1 | Thiopentone Sodium Injectable 1 g Powder | Jagsonpal Pharma | Anesthal | Anesthal 1 gm vial | Vial | 1 | gm | 44.79 | 0 | 0.00% | 44.79 | -- |
| -- | 1.1.7.1 | Thiopentone Sodium Injectable 1 g Powder | Lyka Labs | Thiolyn | Thiolyn Injection 1 gm vial | Vial | 1 | gm | 56.38 | 0 | 0.00% | 56.38 | -- |
| -- | 1.1.7.1 | Thiopentone Sodium Injectable 1 g Powder | Samarth Life Science | Thipen | Injection Thiopentone Sodium 1 gm vial | Vial | 1 | gm | 44.19 | 0 | 0.00% | 44.19 | -- |
-- |
18469000 | 100.00% | -- | -- | |||||||||
-- |
Monopoly situation as only M/s. Neon Labs is the only known manufacturer having substantial market share | -- |
|||||||||||
-- |
PTR per unit | -- | 45 | -- |
|||||||||
-- |
Price fixed in the relevant sub-section for other drugs is as follows: | -- |
|||||||||||
| -- | 1.1: General Anesthetics and Oxygen | ||||||||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- | MRP excl. local taxes (Rs./unit) | S.O. No. | Date | % Reduction w.r.t. to Highest Price | -- |
|||
| -- | 1 | Thiopentone Sodium Injectable 0.5 g gm | S, T | Injection | 0.5 gm | 41.67 | 1st meeting | 1544 | 14.6.2013 | 10.19% | -- |
||
-- |
Therefore, PTR per unit | 45 X (1-10.19%) | 40.41 | -- |
|||||||||
-- |
Add: 16% Retailer Margin | -- | 6.47 | -- |
|||||||||
-- |
Ceiling Price per unit | -- | 46.88 | -- |
|||||||||
-- |
S.O. 3354(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
| -- | 4.2.4 | Desferrioxamine Mesylate | Novartis India | Desferal | Desferrioxamine Mesylate 500mg | Vial | 1 | -- | 170.40 | 27379633 |
-- |
Monopoly situation as only M/s. Novartis is the only known manufacturer | -- |
||||||||
-- |
PTR per unit | -- | 170.40 | -- |
||||||
-- |
Price fixed in the relevant sub-section for other drugs is as follows: | -- |
||||||||
| -- | Section: 4 – Antidotes and Other Substances used in Poisonings | |||||||||
| -- | 4.1: Nonspecific | |||||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Price | Meeting | S.O. | Date | % Reduction as | |
| -- | 1 | Activated Charcoal | P,S,T | Oral | -- | Data NA | -- |
compared to | ||
| -- | 4.2: Specific | -- |
Highest Price | |||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
|||||
| -- | 2 | Atropine Sulphate | P,S,T | Injection | 1 mg/ml | Data NA | -- |
|||
| -- | 3 | Specific Antisnake venom | P,S,T | Injection Polyvalent Solution/ Lyophilyzed Polyvalent Serum | -- | 410.56 | 5th meeting | 2251 | 22.07.2013 | 14.01% |
| -- | 4 | Calcium gluconate | P,S,T | Injection | 100mg/ml | 9.95 | 7th meeting | 2868 | 20.09.2013 | 35.67% |
| -- | 5 | Desferrioxamine mesylate | S, T | Injection | 500mg | -- |
-- | |||
| -- | 6 | Methylthioninium chloride (Methylene blue) | S, T | Injection | 10 mg / ml | Data NA | -- |
-- | ||
| -- | 7 | Penicillamine | S, T | Capsules | 250 mg | 13.12 | 1st meeting | 1567 | 14.6.2013 | 6.54% |
| -- | 8 | Penicillamine | S, T | Tablets | 250 mg | Data NA | -- |
|||
| -- | 9 | Dimercaprol | S, T | Injection in oil | 50 mg / ml | Data NA | -- |
|||
| -- | 10 | Flumazenil | T | Injection | 0.1 mg / ml | Data NA | -- |
|||
| -- | 11 | Sodium Nitrite | S, T | Injection | 30 mg / ml | Data NA | -- |
|||
| -- | 12 | Sodium Thiosulphate | S, T | Injection | 250 mg/ ml | Data NA | -- |
|||
| -- | 13 | Naloxone | P,S,T | Injection | 0.4mg/ml | 91.51 | 5th meeting | 2234 | 22.07.2013 | 27.06% |
| -- | 14 | Pralidoxime Chloride(2-PAM) | P,S,T | Injection | 25 mg/ml | Data NA | -- |
-- | ||
| -- | Added medicines: | -- |
-- | |||||||
| -- | 15 | N-acetylcysteine | P,S,T | Injection | 200 mg/ml(5 ml) | 22.52 | 1st meeting | 1568 | 14.6.2013 | 40.73% |
-- |
Average Reduction | 24.80% | ||||||||
-- |
Therefore, PTR per unit | 170.4 X (1-24.80%) | 128.14 | -- |
||||||
-- |
Add: 16% Retailer Margin | -- | 20.50 | -- |
||||||
-- |
Ceiling Price per unit | -- | 148.64 | -- |
||||||
-- |
S.O. 3355(E) dated 05.11.2013 | -- |
||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 6.1.3.1.1 | Praziquantel Tablet 600 mg | CHANDRA BHAGAT | DISTOSIDE TABLET | PACK OF 8 TABS i.e. 2 BLISTERS OF 4 TABS | Tablets | 8 | Per Tab | 251.43 | 203000 | 31.43 | 23.87 |
-- |
Monopoly situation as only one company i.e. M/s Chandra Bhagat Pharma Pvt. Ltd has given the data. | -- |
||||||||||
-- |
PTR per unit as per data given by company | -- | 31.43 | -- |
||||||||
-- |
Prices fixed in the relevant sub -section is as follows: | -- |
||||||||||
-- |
6.1.1 Intestinal Anthelminthics | -- |
||||||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | ceiling price | Meeting No. /date | notified vide so. no | % reduction to the highest pack | -- |
|||
| -- | 1 | Albendazole | P,S,T | Tablets | 400 mg | 9.12 | 2nd Meeting | 1793 dt. 21.6.13 | 43.95% | -- |
||
| -- | 2 | Albendazole | -- | Suspension | 200 mg/ 5 ml | 1.48 | 2nd Meeting | 1794 dt. 21.6.13 | 36.93% | -- |
||
| -- | Added Medicines | -- |
-- | -- |
||||||||
| -- | 3 | Piperazine | P,S,T | Solution | 750mg/5ml | 0.28 | 7th meeting | 2834(E) dt. 20.9.2013 | 40.44% | -- |
||
| -- | 6.1.2 Antifilarials | -- |
-- | -- |
||||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- | -- |
|||||
| -- | 4 | Diethylcarbamazine citrate | P,S,T | Tablets | 50 mg | 0.47 | 1st meeting | 1574 (E) dt. 14.6.13 | 16.75% | -- |
||
-- |
6.1.3 Antichistosomals and antitrematode Medicines | -- |
-- | -- |
||||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- | -- |
|||||
| -- | 5 | Praziquantel | S, T | Tablets | 600 mg | -- | -- | -- | -- | -- |
||
-- |
Average Reduction | -- |
34.52% | -- |
||||||||
-- |
-- | -- |
-- | -- |
||||||||
-- |
Therfore,per unit price as per Para 6(iii) of DPCO,2013 | -- | 31.43*(1-34.52%) | 20.58 | -- |
|||||||
-- |
Add margin 16% | -- |
3.29 | -- |
||||||||
-- |
Ceiling Price | -- |
23.87 | -- |
||||||||
-- |
S.O. 3356(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 6.2.4.2.2.1 | Isoniazid Syrup 100mg/5ml | Albert David Ltd. | Siozide Syrup | Isoniazid Syrup 100mg/5ml | syrup | 200ml | ml | 41.58 | 1400664 | -- | 0.21 | 0.22 |
-- |
Monopoly situation as data is available for one company i.e. M/s ALBERT DAVID. | -- |
|||||||||||
-- |
PTR per unit as per available data | -- | -- | -- |
0.21 | -- | -- | -- |
|||||
-- |
Prices fixed in the relevant sub -section is as follows: | -- |
|||||||||||
-- |
6.2.4 Antituberculosis medicines | -- |
|||||||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
||||||||
| -- | 1 | Isoniazid | P,S,T | Tablets | 50 mg | nil | -- |
||||||
| -- | 2 | Isoniazid | P,S,T | Tablets | 100 mg | 0.72 | 7th meeting | 2838 (E) dt.20.9.13 | 9.70% | -- |
|||
| -- | 3 | Isoniazid | P,S,T | Tablets | 300 mg | 1.27 | 5th Meeting | 2238 (E) dt.22.7.13 | 9.70% | -- |
|||
| -- | 4 | Isoniazid | P,S,T | Syrup | 100 mg/5ml | -- |
-- | -- |
|||||
-- |
Average Reduction | -- |
9.70% | -- |
|||||||||
-- |
-- | -- |
|||||||||||
-- |
Therfore,per unit price as per Para 6(ii) of DPCO,2013 | -- | 0.21*(1-9.7%) | -- | 0.19 | -- |
|||||||
-- |
Add margin 16% | -- |
0.03 | -- |
|||||||||
-- |
Ceiling Price | -- |
0.22 | -- |
|||||||||
-- |
S.O. 3357(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 6.3.2.2 | Clotrimazole Pessaries 200 mg | GLENMARK | CANDID V-3 TABS | CANDID V-3 TABS | SUPPOSITORIES | 3 | SUPPOSITORIES | 38.35 | 18124000 | 12.78 | 12.71 |
-- |
Monopoly situation as data is available for one company i.e. M/s Glenmark. | -- |
||||||||||
-- |
PTR per unit as per available data | -- | 12.78 | -- |
-- | -- | -- | -- | ||||
-- |
Prices fixed in the relevant sub -section is as follows: | -- |
||||||||||
-- |
6.3 Antifungal medicines | -- |
||||||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | -- |
|||
| -- | 1 | Clotrimazole | P,S,T | Pessaries | 100 mg | 8.47 | proposed in agenda of 8th meeting | -- | 17.30% | -- |
||
| -- | 2 | Clotrimazole | P,S,T | Pessaries | 200 mg | nil | -- |
-- | -- |
|||
| -- | 3 | Clotrimazole | P,S,T | Gel | 0.02 or 2% | 2.07 | 3rd Meeting | 1886 (E) dt. 28.6.13 | 11.23% | -- |
||
-- |
Average Reduction | -- |
14.27% | -- |
||||||||
-- |
-- | -- |
||||||||||
-- |
Therfore,per unit price as per Para 6(i) of DPCO,2013 | -- |
12.78*(1-14.27%) | 10.96 | -- |
|||||||
-- |
Add margin 16% | -- |
1.75 | -- |
||||||||
-- |
Ceiling Price | -- |
12.71 | -- |
||||||||
-- |
S.O. 3358(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 6.4.10.1 | Efavirenz Capsules 200 mg | CIPLA | EFAVIR | EFAVIR CAPS 200 MG x 30 | Capsules | 30 | Per cap | 657.90 | 2288176 | 21.93 | 23.16 |
-- |
Monopoly situation as IMS Health has data is for one company i.e. M/s cipla | -- |
||||||||||
-- |
PTR per unit as per IMS Health data | -- | 21.93 | -- |
||||||||
-- |
Prices fixed in the relevant sub -section is as follows: | -- |
||||||||||
-- |
6.4.2.2 Non-nucleoside reverse transcriptase inhibitors | -- |
||||||||||
| -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % Reduction to highest price pack | -- |
|||
| -- | Efavirenz | S, T | Capsules | 200 mg | -- |
|||||||
| -- | Efavirenz | -- | Capsules | 600 mg | nil | -- | -- |
|||||
| -- | Nevirapine | S, T | Capsules | 200 mg | nil | -- |
||||||
| -- | Nevirapine | -- | Suspension | 50 mg / 5 ml | 0.98 | 1st meeting | 1595 (E) dt. 14.06.13 | 8.94 | -- |
|||
-- |
Average Reduction | -- |
8.94 | -- |
||||||||
-- |
Therfore,per unit price as per Para 6(ii) of DPCO,2013 | 21.93*(1-8.94%) | 19.97 | -- |
||||||||
-- |
Add margin 16% | -- | 3.20 | -- |
||||||||
-- |
Ceiling Price | -- | 23.16 | -- |
||||||||
-- |
S.O. 3359(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|
| -- | 6.4.14.1 | Ritonavir Capsules 100 mg | CIPLA | RITOMUNE | RITOMUNE CAPS 100 MG x 60 | 60 | 2031.1 | 5356090 | 33.85 | 34.22 |
-- |
Monopoly situation as data is available for one company i.e. M/s Cipla. | -- |
||||||||
-- |
PTR per unit as per available data | -- | 33.852186 | -- |
-- | -- | ||||
-- |
Prices fixed in the relevant sub -section is as follows: | -- |
||||||||
-- |
6.4.2.3 Protease inhibitors | -- |
||||||||
| -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | -- |
|
| -- | Indinavir | S, T | Capsules | 200 mg | nil | 7th meeting | -- |
|||
| -- | Indinavir | S, T | Capsules | 400 mg | 19.41 | 1st meeting | 1596 (E) dt. 14.06.13 | 12.85 | -- |
|
| -- | Nelfinavir | S, T | Capsules | 250 mg | -- |
|||||
| -- | Ritonavir | S, T | Capsules | 100 mg | -- | -- | -- | -- | -- |
|
| -- | Ritonavir | S, T | Syrup | 400 mg / 5ml | nil | -- |
||||
| -- | Saquinavir | S, T | Capsules | 200 mg | nil | -- |
||||
| -- | Average reduction | -- |
12.85 | -- |
||||||
| -- | Therfore,per unit price as per Para 6(ii) of DPCO,2013 | -- |
33.85*(1-12.85%) | 29.50 | -- |
|||||
| -- | Add margin 16% | -- |
4.72 | -- |
||||||
| -- | Ceiling Price | -- |
34.22 | -- |
||||||
-- |
S.O. 3360(E) dated 05.11.2013 | -- |
||||||||
| S.No. | Unique No. as per NLEM | Composition | Company | Brands | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | Price per Unit |
|---|---|---|---|---|---|---|---|---|---|
| -- | 6.5.1.1 | Each Uncoated Tablet Contains : Diloxanide Furoate – 500 mg | Franco Indian Remedies Pvt. Limited, Chennai | Amicline Tablet | tablet | 10 | 18.24 | 2790000 | 1.82 |
-- |
Monopoly situation as only one company i.e. M/s Franco Indian Remedies Pvt. Ltd has given the data. | -- |
|||||||
-- |
PTR per unit as per data given by company | -- | 1.82 | -- |
|||||
-- |
Prices fixed in the relevant sub -section is as follows: | -- |
|||||||
-- |
6.5.1 Antiprotozoal Medicines | -- |
|||||||
-- |
6.5.1 Antiamoebic and Antigiardiasis Medicines | -- |
|||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | |
| -- | 1 | Diloxanide Furoate | P,S,T | Tablets | 500 mg | -- | -- |
||
| -- | 6.5.2 Antileishmaniasls medicines | -- |
|||||||
| -- | 2 | Amphotericin B | S,T | Injection | 50 mg | 4245.32 | 3rd Meeting | 1912 (E) dt. 28.06.13 | 57.77 |
| -- | 3 | Pentamidine Isothionate | S, T | Injection | 200 mg | nil | -- |
||
| -- | 4 | Sodium Stibogluconate | S, T | Injection | 100 mg / ml | nil | -- |
||
-- |
6.5.3 Antimalarial Medicines | -- |
|||||||
-- |
6.5.3.1 For curative treatment | -- |
|||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
||||
| -- | 5 | Artesunate (To be used only in combination with Sulfadoxine +Pyrimethamine) | P,S,T | Tablets | 50 mg | 20.04 | 2nd Meeting | 1826(E) dt. 21.06.2013 | 26.77 |
| -- | 6 | Primaquine | P,S,T | Tablets | 2.5 mg | 1.55 | 2nd Meeting | 1821(E) dt.21.07.13 | 38.7 |
| -- | 7 | Primaquine | -- | Tablets | 7.5 mg | 1.98 | 1st meeting | 1597 (E) dt. 14.06.13 | 4.47 |
-- |
Pyrimethamine | P,S,T | Tablets | 25 mg | nil | -- |
|||
| -- | 8 | Quinine sulphate | P,S,T | Tablets | 300 mg | 5.1 | 1st meeting | 1598 (E) dt. 14.06.13 | 19.37 |
| -- | 9 | Quinine sulphate | ST | Injection | 300 mg / ml | 9.07 | 1st meeting | 1599 (E) dt. 14.06.13 | 10.28 |
-- |
Medicines added | -- |
|||||||
-- |
6.5.3.1 For curative treatment | -- |
|||||||
-- |
Clindamycin | S,T | Tablet | 150mg | -- |
||||
-- |
Clindamycin | S,T | Tablet | 300mg | 13.09 | 8th meeting | -- | 11.29 | |
-- |
6.5.3.2 For prophylaxis | -- |
|||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
||||
-- |
Medicines added | -- |
|||||||
-- |
Mefloquine | S,T | Tablet | 250 mg base | 50.06 | 1st meeting | 1600 (E) dt. 14.6.13 | 20.99 | |
-- |
6.5.4 Antipneumocystosis and Antitoxoplasmosis medicines | -- |
|||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
||||
-- |
Co-Trimoxazole (Trimethoprim + Sulphamethoxazole) | P,S,T | Tablets | 80 + 400 mg | DPCO 1995 product | -- |
|||
-- |
Co-Trimoxazole (Trimethoprim + Sulphamethoxazole) | P,S,T | Tablets | 160+800 mg | DPCO 1995 product | -- |
|||
-- |
Co-Trimoxazole (Trimethoprim + Sulphamethoxazole) | P,S,T | Suspension | 40 + 200 mg / 5 ml | DPCO 1995 product | -- |
|||
-- |
Pentamidine Isothionate | S, T | Injection | 200 mg | nil | -- |
|||
-- |
Average Reduction | -- |
23.71 | ||||||
-- |
Therfore,per unit price as per Para 6(ii) of DPCO,2013 | -- | 1.82*(1-23.71%) | 1.39 | -- |
||||
-- |
Add margin 16% | -- |
0.22 | -- |
|||||
-- |
Ceiling Price | -- |
1.61 | -- |
|||||
-- |
S.O. 3361(E) dated 05.11.2013 | -- |
|||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 6.5.3.1 | Sodium Stibogluconate Injection 100 mg / ml | ALBERT DAVID | SODIUM STIBOGLUCO. | SODIUM STIBOGLUCO. INJ VIAL 30 ML x 1 | Vials | 30 | ML | 199.41 | 4932684 | 6.65 | -- |
-- |
Monopoly situation as IMS Health has data is for one company i.e. M/s ALBERT DAVID. | -- |
||||||||||
-- |
PTR per unit as per IMS Health data | -- | 6.65 | -- |
||||||||
-- |
Prices fixed in the relevant sub -section is as follows: | -- |
3.26 | |||||||||
-- |
6.5.1 Antiprotozoal Medicines | -- |
||||||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | -- |
|||
| -- | 6.5.2 Antileishmaniasls medicines | -- |
||||||||||
| -- | 1 | Amphotericin B | S, T | Injection | 50 mg | 4245.32 | 3rd Meeting | 1912 (E) dt. 28.06.13 | 57.77 | -- |
||
| -- | 2 | Pentamidine Isothionate | S, T | Injection | 200 mg | nil | -- |
|||||
| -- | 3 | Sodium Stibogluconate | S, T | Injection | 100 mg / ml | -- | -- |
|||||
| -- | Average Reduction | -- |
57.77 | -- |
||||||||
| -- | -- | -- |
||||||||||
-- |
Therfore,per unit price as per Para 6(ii) of DPCO,2013 | 6.65*(1-57.77%) | S, T | 2.81 | -- |
|||||||
-- |
Add margin 16% | -- |
0.45 | -- |
||||||||
-- |
Ceiling Price | -- |
3.26 | -- |
||||||||
-- |
S.O. 3362(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.2.4.1 | Busulphan tablet 2 mg | NEON LABORATORIES LTD | BURAN | tablet | 10 | 40 | 20000 | 4.00 | -- |
-- |
Monopoly situation as data is available for one company i.e. M/s Neon Labs Ltd. | -- |
||||||||
-- |
PTR per unit as per available data | -- | 4 | -- |
-- | -- | ||||
-- |
Prices fixed in the relevant sub -section is as follows: | -- |
||||||||
-- |
8.2: Cytotoxic medicines | -- |
||||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | -- | |
| -- | 1 | Actinomycin D | T | Injection | 0.5 mg | nil | -- |
|||
| -- | 2 | Alpha Interferon | T | Injection | 3 million IU | 759.7 | 1st Meeting | 1604 (E) dt. 14.06.13 | 33.85 | -- |
| -- | 3 | Bleomycin | T | Injection | 15 mg | 616.06 | 1st Meeting | 1605 (E) dt. 14.06.13 | 22.71 | -- |
| -- | 4 | Busulphan | T | Tablets | 2 mg | -- |
||||
| -- | 5 | Cisplatin | T | Injection | 10 mg / vial | 84.84 | 5th meeting | 2241 (E) dt. 22.07.13 | 35.67 | -- |
| -- | 6 | Cisplatin | T | Injection | 50 mg / vial | 301.26 | 3rd meeting | 1890 (E) dt. 28.08.13 | 102.31 | -- |
| -- | 7 | Cyclophosphamide | T | Tablets | 50 mg | 3.75 | 1st Meeting | 1606 (E) dt. 14.06.13 | 24.89 | -- |
| -- | 8 | Cyclophosphamide | T | Tablets | 200 mg | nil | 7th meeting | -- | -- | -- |
| -- | 9 | Cyclophosphamide | -- | Injection | 500 mg | 72.71 | 6th Meeting | 2529 (E) dt. 21.08.13 | 16.32 | -- |
| -- | 10 | Cytosine arabinoside | T | injection | 100mg/vial | 238.44 | 3rd meeting | 1914 (E) dt. 28.08.13 | 27.7 | -- |
| -- | 11 | Cytosine arabinoside | T | injection | 500mg/vial | 515.53 | 3rd meeting | 1891 (E) dt. 28.08.13 | 2.18 | -- |
| -- | 12 | Cytosine arabinoside | T | injection | 1000mg/vial | 1170.62 | 3rd meeting | 1892 (E) dt. 28.08.13 | 35.09 | -- |
| -- | 13 | Danazol | T | Capsules | 50 mg | 9.37 | 1st Meeting | 1607 (E) dt. 14.06.13 | 32.58 | -- |
| -- | 14 | Danazol | -- | Capsules | 100 mg | 20.33 | 1st Meeting | 1608 (E) dt. 14.06.13 | 25.86 | -- |
| -- | 15 | Doxorubicin | T | Injection | 10 mg | 196.48 | 3rd Meeting | 1893 (E) dt. 28.06.13 | 24.72 | -- |
| -- | 16 | Doxorubicin | T | Injection | 50 mg | 1145.2 | 1st Meeting | 1609 (E) dt. 14.06.13 | 43.33 | -- |
| -- | 17 | Etoposide | T | Capsules | 100 mg | 209.19 | 8th meeting | -- | 9.83 | -- |
| -- | 18 | Etoposide | -- | Injection | 100 mg/ 5 ml vial | 192.39 | 3rd meeting | 1915 (E) dt. 28.08.13 | 9.83 | -- |
| -- | 19 | Flutamide | T | Tablet | 250 mg | 8.62 | 3rd Meeting | 1894 (E) dt. 28.06.13 | 3.02 | -- |
| -- | 20 | 5-Fluorouracil | T | Injection | 250 mg / 5 ml | -- | -- |
|||
| -- | 21 | Gemcitabine hydrochloride | T | Injection | 200 mg | 1304.86 | 1st Meeting | 1610 (E) dt. 14.06.13 | 27.8 | -- |
| -- | 22 | Gemcitabine hydrochloride | -- |
1 gm | 5969.16 | 1st Meeting | 1611 (E) dt. 14.06.13 | 25.4 | -- | |
| -- | 23 | Methotrexate | T | Tablet | 2.5 mg | 4.72 | 1st Meeting | 1612 (E) dt. 14.06.13 | 17.49 | -- |
| -- | 24 | Methotrexate | -- | Injection | 50 mg / ml | 33.18 | 5th Meeting | 2242 (E) dt. 22.07.13 | 27.15 | -- |
| -- | 25 | Vincristine | T | Injection | 1 mg / ml | 50.6 | 1st Meeting | 1613 (E) dt. 14.06.13 | 10.68 | -- |
-- |
Average reduction | -- |
26.5909524 | -- | ||||||
-- |
Therfore,per unit price as per Para 6(ii) of DPCO,2013 | -- | 4*(1-26.59%) | 2.94 | -- |
|||||
-- |
Add margin 16% | -- |
0.47 | -- |
||||||
-- |
Ceiling Price | -- |
3.41 | -- |
||||||
-- |
S.O. 3363(E) dated 05.11.2013 | -- |
||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | Price to Retailer per unit |
|---|---|---|---|---|---|---|---|---|---|---|
| -- | 8.2.10.1 | Each capsule contains Etoposide 100 mg | Khandelwal Laboratories Pvt. Ltd. | Lastet | Capsules | 4’s strip | Capsules | 200.00 | 17000 | 50.00 |
-- |
Monopoly situation as data is available for one company i.e. M/s Khandelwal Labs Pvt. Ltd. | -- |
||||||||
-- |
PTR per unit as per available data | -- | 200 | -- |
-- | -- | ||||
-- |
Prices fixed in the relevant sub -section is as follows: | -- |
||||||||
-- |
8.2: Cytotoxic medicines | -- |
||||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | -- | |
| -- | 1 | Etoposide | T | Capsules | 100 mg | -- |
||||
| -- | 2 | Etoposide | -- | Injection | 100 mg/ 5 ml vial | 192.39 | 3rd meeting | 1915 (E) dt. 28.08.13 | 9.83 | -- |
-- |
Average Reduction | -- |
9.83 | -- | ||||||
| -- | -- | -- |
||||||||
-- |
Therfore,per unit price as per Para 6(i) of DPCO,2013 | -- | 50*(1-9.83%) | 45.09 | -- |
|||||
-- |
Add margin 16% | -- |
7.21 | -- |
||||||
-- |
Ceiling Price | -- |
52.30 | -- |
||||||
-- |
S.O. 3364(E) dated 05.11.2013 | -- |
||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | Price to Retailer (Rs.) | MAT Value as on 31st May 2012 (Rs.) | Price per Unit (Rs.) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 10.1.3.1 | Folic Acid Tablets 1 mg | JUGGAT PHARMA | B-9 | B-9 TAB UNCOATED 1 MG x 30 | Tablet | 30 | Per Tabs | 12.44 | 412895 | 0.41 |
-- |
-- | -- | |||||||||
-- |
Monopoly situation as IMS Health has data is for one company i.e. M/s Juggat Pharma | -- |
|||||||||
-- |
PTR per unit as per Company data is-0.41 | -- |
|||||||||
-- |
Prices fixed in the relevant sub -section for the schedule formulation is as follows: | -- |
|||||||||
-- |
10.1- Antianaemia medicine | -- |
|||||||||
| S.No. | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | S.O. No. & Date | % reduction to Highest price pack |
| 3 | Folic Acid | P, S, T | Tablets | 5 mg | 1.15 | 1620(E) dated 14.06.2013 | 48.07 |
| 3 | Folic Acid | P, S, T | Tablets | 1 mg | Under consideration | -- |
|
| A | Average Reduction | -- |
48.07 | ||||
| B | Therfore,per unit price for Folic Acid 1 mg as per Para 6(i) of DPCO,2013 | 0.41*(1-48.07%) | -- |
0.22 | -- |
||
| C | Add margin 16% | -- |
0.03 | -- |
|||
| D | Ceiling Price per Tablet (Rs.) | -- |
0.25 | -- |
|||
-- |
S.O. 3365(E) dated 05.11.2013 | -- | |||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Type | Dosage Form | Pack Size ml | Price to Retailer | MAT Value as on 31st May 2012 | – | Price per unit (ML) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 11.1.4.1 | Hydroxyethyl Starch Injection 6 % | Claris Life science | Hetastarch -200 | Plastic Bottle | inj | 500 | 309.31 | 42568788.8 | -- | 0.62 |
| -- | 11.1.4.1 | Hydroxyethyl Starch Injection 6 % | Claris Life science | Hetastarch -450 | Plastic Bottle | inj | 500 | 343.01 | 17373456.5 | -- | 0.69 |
| -- | 11.1.4.1 | Hydroxyethyl Starch Injection 6 % | Claris Life science | TetraHES-130 | Plastic Bottle | inj | 500 | 380.16 | 8398874.88 | -- | 0.76 |
| -- | 11.1.4.1 | Hydroxyethyl Starch Injection 6 % | Claris Life science | TetraHES-130 | Plastic Bottle | inj | 500 | 425.09 | 9012333.09 | -- | 0.85 |
-- |
Total | -- |
1457.57 | 77353453.2 | -- | 2.92 | |||||
-- |
Average Price | -- |
0.73 | ||||||||
-- |
Monopoly situation as data is available for one company i.e. M/s Claris Life Science | -- |
|||||||||
-- |
PTR per unit as per Company data is – Re. 0.73 | -- |
|||||||||
-- |
Prices fixed / proposed in the relevant sub -section for the schedule formulation is as follows: | -- |
|||||||||
-- |
11.1 Plasma Substitutes | -- |
|||||||||
-- |
-- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price (without local taxes) | S.O. No. Date/ Propsal | -- | % reduction to Highest price pack | % reduction to Highest price pack | |
-- |
1 | Dextran-40 | P, S, T | inj. | 0.1 | 0.75 | Proposed in the 140th Meeting | -- | 48.07 | 12.47 | |
-- |
2 | Dextran-70 | P, S, T | inj. | 0.06 | -- | No data | -- |
|||
-- |
3 | Fresh frozen plasma | T | inj. | -- |
No data | -- |
||||
-- |
4 | Hydroxyethyl Starch (Hetastarch) | S, T | inj. | 0.06 | -- | under consideration | -- |
|||
-- |
5 | Polygeline | S, T | inj. | 0.035 | -- | No data | -- |
|||
-- |
A | Average Reduction | -- |
48.07 | 12.47 | ||||||
-- |
B | Therfore,per unit price for Hydroxyethyl Starch as per Para 6(ii) of DPCO,2013 | -- | 0.73*(1-12.47%) | -- | 0.64 | -- |
||||
-- |
C | Add margin 16% | -- |
0.10 | -- |
||||||
-- |
D | Ceiling Price per ML (withoutlocal taxes) (Rs.) | -- |
0.74 | -- |
||||||
-- |
S.O. 3366(E) dated 05.11.2013 | -- |
|||||||||
Pricing of NLEM Drug Digoxin inj 0.25mg/ ml
Pricing of NLEM Drug Digoxin inj 0.25mg/ ml
| S. No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | Price per Unit |
| 1 | 12.4.1.2 | Digoxin inj. 0.25mg/ml | SAMARTH PHARMA | DIXIN | DIXIN INJ AMP 0.25 MG 2 ML x 1 (/1ML) | Inj | 2 | ML | 6.40 | 683155 | 3.20 |
-- |
-- | -- |
|||||||||
| -- | Monopoly situation as IMS Health has data is for one company i.e. M/s Samarth Pharma | -- |
|||||||||
| -- | PTR per unit as per IMS Health data- 3.20 per ml | -- |
|||||||||
| -- | Prices fixed in the relevant sub -section is as follows: | -- |
|||||||||
| -- | 12.4 Medicines Used in heart failure | -- |
|||||||||
| -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price (Rs/ unit.) | S.O. No. & Date | -- | % reduction to Highest price pack | -- |
||
| 1 | Digoxin | S T | Tablets | 0.25 mg | 1.26 | 1641 (E) dated 14.06.2013 | -- | 23.05 | -- |
||
| 2 | Digoxin | S, T | injection | 0.25/ml | -- | Under Consideration | -- |
||||
| 3 | Digoxin | S, T | Elixir | 0.05mg/ml | -- | No Data | -- |
||||
| -- | Average Reduction | -- |
23.05 | -- |
|||||||
| -- | -- | -- |
|||||||||
| -- | Therfore,per unit price as per Para 6(i) of DPCO,2013 | -- | 3.20*(1-23.05%) | -- | 2.46 | -- |
|||||
| -- | Add margin 16% | -- |
0.39 | -- |
|||||||
| -- | Ceiling Price (Rs.)/ML | -- |
2.85 | -- |
|||||||
-- |
S.O. 3367(E) dated 05.11.2013 | -- |
|||||||||
| Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | PTR Rs. |
MAT Value as on 31st May 2012 | MAT % | Price per tablet | Ceiling Price with 16% Margin |
| 17.3.1.1 | 5-Amino Salicylic Acid | Wallace Pharmaceuticals Pvt Ltd | Walasa | 400mg | Tablet | 10 | Tablet | 56.2 | 7838331 | 1 | 5.62 | -- |
-- |
7838331 | 1 | -- |
|||||||||
| -- | Monopoly situation as M/s Wallace Pharmaceuticals Pvt Ltd. is the only company manufacturing the formulation and has market share of 100% | -- |
||||||||||
| -- | PTR per tablet | -- | 5.62 | -- |
||||||||
| -- | Price fixed in the relevant sub-section for other drugs is as follows: | -- |
||||||||||
| Unique No. as per NLEM | Medicines | Category | Route of Admn | Strength | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O No | Date | % Reduction w.r.t. Highest Price |
| 17.1.2.1 | Omeprazole | P,S, T | Capsules | 10mg | 2.76 | 2nd | 1828 | 21.06.2013 | 30.50% |
| 17.1.2.2 | Omeprazole | P,S, T | Capsules | 20mg | 3.02 | 2nd | 1829 | 21.06.2013 | 192.11% |
| 17.1.4.1 | Pantoprazole | T | Injection | 40mg | 47.93 | 1st | 1653 | 14.06.2013 | 32.04% |
| 17.2.1.1.1 | Domperidone | P,S, T | Tablets | 10mg | 2.26 | 4th | 2063 | 05.07.2013 | 46.32% |
| 17.2.1.2.2 | Domperidone | P,S, T | Syrup | 1mg/ml | 1.03 | 1st | 1654 | 14.06.2013 | 54.71% |
| 17.2.2.1.1 | Metoclopramide | P,S, T | Tablets | 10mg | 1.04 | 1st | 1655 | 14.06.2013 | 42.03% |
| 17.2.2.2.2 | Metoclopramide | P,S, T | Syrup | 5mg/5ml | 0.47 | 1st | 1656 | 14.06.2013 | 28.64% |
| 17.2.2.3.3 | Metoclopramide | P,S, T | Injection | 5mg/ml | 2.09 | 1st | 1657 | 14.06.2013 | 41.81% |
| 17.2.3.1.1 | Promethazine | P,S, T | Tablets | 10mg | 0.93 | -- | 2832 | 20.09.2013 | 28.00% |
| 17.2.3.1.2 | Promethazine | P,S, T | Tablets | 25mg | 2.49 | 1st | 1566 | 14.06.2013 | 12.70% |
| 17.2.3.3.3 | Promethazine | P,S, T | Injection | 5mg/5ml | 0.21 | 1st | 1552 | 14.06.2013 | 43.30% |
| 17.2.3.3.4 | Promethazine | P,S, T | Injection | 25mg/ml | 2.66 | 3rd | 1918 | 28.06.2013 | 36.07% |
| 17.2.4.1.1 | Ondansetron | S,T | Tablets | 4mg | 4.76 | 5th | 2244 | 22.07.2013 | 45.26% |
| 17.2.4.1.2 | Ondansetron | S,T | Tablets | 8mg | 11.07 | 1st | 1618 | 14.06.2013 | 29.02% |
| 17.2.4.2.3 | Ondansetron | S,T | Syrup | 2mg/ml | 1.04 | 2nd | 1804 | 21.06.2013 | 13.99% |
| 17.2.4.3.4 | Ondansetron | S,T | Injection | 2mg/ml | 7.37 | 2nd | 1803 | 21.06.2013 | 46.18% |
| 17.4.1.2.2 | Dicyclomine Hydrochloride | P,S, T | Injection | 10mg/ml | 2.95 | 4th | 2064 | 05.07.2013 | 65.44% |
| 17.4.2.1.1 | Hyoscine Butyl Bromide | P,S, T | Tablets | 10mg | 2.83 | -- |
12.37% | ||
| 17.4.2.2.2 | Hyoscine Butyl Bromide | P,S, T | Injection | 20mg/ml | 9.84 | 1st | 1658 | 14.06.2013 | 1.28% |
| 17.5.1.1.1 | Bisacodyl | P,S, T | Tablets | 5mg | 0.97 | 4th | 2065 | 05.07.2013 | 35.04% |
| 17.5.1.2.1 | Bisacodyl | P,S, T | Suppository | 5mg | 7.97 | -- |
35.04% | ||
| 17.5.2.1 | Ispaghula | P,S, T | Granules | NA | 0.76 | 2nd | 1813 | 21.06.2013 | 29.31% |
| 17.6.1.1.1 | Oral Rehydration salts | P,S, T | Powder of solution | NA | 0.84 | 6th | 2531 | 21.08.2013 | 22.96% |
-- |
924.12% | ||||||||
| -- | Therefore, PTR per unit | 5.62 X (1-40.18%) | 3.36 | -- |
-- | ||||
| -- | Add: 16% Retailer Margin | -- | 0.54 | -- |
Average % Reduction | 40.18% | |||
| -- | Ceiling Price per unit | -- | 3.90 | -- |
|||||
-- |
S.O. 3368(E) dated 05.11.2013 | -- |
|||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | PTR/Strip | MAT Value as on 31st May 2012 | MAT % | Price per Supp. | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 17.5.1.1 | Bisacodyl 5mg. | Cadila Healthcare Ltd. | Dulcolax | 5mg | Suppository | 5 | 5’s Strip | 52.89 | 44109984 | 100.0% | 10.58 | -- |
-- |
44109984 | 100.0% | -- |
||||||||||
-- |
Monopoly situation as M/s Cadila Healthcare is the only company manufacturing the formulation and has market share more than 1% | -- |
|||||||||||
-- |
PTR per unit | -- | 10.58 | -- |
|||||||||
-- |
Price fixed in the relevant sub-section for other drugs is as follows: | -- |
|||||||||||
-- |
Medicines | Category | Route of Admn | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O No. | Date | -- | % Reduction w.r.t. Highest Price | -- |
||
-- |
Bisacodyl 5mg tablets | S, T | Tablets | 5mg | 0.97 | 4th meeting | 2065 | 05.07.2013 | -- | 35.04% | -- |
||
-- |
Therefore, PTR per unit | 10.58 X (1-35.04%) | 6.87 | -- |
|||||||||
-- |
Add: 16% Retailer Margin | -- | 1.10 | -- |
|||||||||
-- |
Ceiling Price per unit | -- | 7.97 | -- |
|||||||||
-- |
S.O. 3369(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Desc. | Dosage Form | Pack Size | Unit | PTR | MAT Value as on 31st May 2012 | MAT % | Price per tablet | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 18.4.1.2 | Ethinylestradiol I.P 0.05 mg | Organon (India) Pvt Ltd | Lynoral | 0.05 mg | Tablet | 10 | Per strip | 51.81 | 23620616 | 100.00% | 5.18 | -- |
-- |
23620616 | 100.00% | 5.18 | -- | |||||||||
-- |
Monopoly situation as M/s Organon (India) Pvt Ltd is the only company manufacturing the formulation and has market share of 100% | -- |
|||||||||||
-- |
PTR per unit | -- | 10.58 | -- |
|||||||||
-- |
Price fixed in the relevant sub-section for other drugs is as follows: | -- |
|||||||||||
-- |
Medicines | Category | Route of Admn | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O No. | Date | -- | % Reduction w.r.t. Highest Price | -- |
||
-- |
Ethinylestradiol I.P 0.01mg | S, T | Tablets | 5mg | 2.12 | 1st meeting | 1660 | 14.06.2013 | -- | 41.33% | -- |
||
-- |
Therefore, PTR per unit | 5.18 X (1-41.33%) | 3.04 | -- |
|||||||||
-- |
Add: 16% Retailer Margin | -- | 0.49 | -- |
|||||||||
-- |
Ceiling Price per unit | -- | 3.53 | -- |
|||||||||
-- |
S.O. 3370(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | PTR Rs. |
MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 19.2.3.1 | Antitetanus Human Immunoglobin | Bharat Serums and Vaccines Ltd | Tetglob | 250 IU | Injection | 1 | 1 | 914.09 | 104810000 | 100.0% | 914.09 | -- |
-- |
104810000 | 100.0% | -- |
||||||||||
-- |
Monopoly situation as M/s Bharat Serums and Vaccines Ltd. is the only company manufacturing the formulation and has market share of 100% | -- |
|||||||||||
-- |
PTR per unit | -- | 914.09 | -- |
|||||||||
-- |
Price fixed in the relevant sub-section for other drugs is as follows: | -- |
|||||||||||
-- |
Medicines | Category | Route of Admn | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O No | Date | -- | % Reduction w.r.t. Highest Price | -- |
||
-- |
Anti-D Immunoglobin (Human) | S, T | Injection | 300 ug | 2209.8 | 1st | 1670 | 14.06.2013 | -- | 19.28% | -- |
||
-- |
Polyvalent Antisnake Venom | P,S,T | Injection | 10ml | 410.56 | 5th | 2251 | 22.07.2013 | -- | 14.01% | -- |
||
-- |
Diphtheria Antitoxin | S.T | Injection | 10000 IU | 1156 | -- |
4.46% | -- |
|||||
-- |
Rabies Immunoglobin | P,S,T | Injection | 150 IU/ml | 1255.84 | -- |
48.33% | -- |
|||||
-- |
Average % Reduction | -- | 21.52% | -- |
|||||||||
-- |
Therefore, PTR per unit | 914.09 X (1-21.52%) | 717.38 | -- |
|||||||||
-- |
Add: 16% Retailer Margin | -- | 114.78 | -- |
|||||||||
-- |
Ceiling Price per unit | -- | 832.16 | -- |
|||||||||
-- |
S.O. 3371(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | PTR Rs. |
MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 19.2.3.2 | Antitetanus Human Immunoglobin | Bharat Serums and Vaccines Ltd | Tetglob | 500 IU | Injection | 1 | 1 | 1523.81 | 30963000 | 1 | 1523.81 | -- |
-- |
30963000 | 1 | -- |
||||||||||
-- |
Monopoly situation as M/s Bharat Serums and Vaccines Ltd. is the only company manufacturing the formulation and has market share of 100% | -- |
|||||||||||
-- |
PTR per unit | -- | 1523.81 | -- |
|||||||||
-- |
Price fixed in the relevant sub-section for other drugs is as follows: | -- |
|||||||||||
-- |
Medicines | Category | Route of Admn | Strengths | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O No | Date | -- | % Reduction w.r.t. Highest Price | -- |
||
-- |
Anti-D Immunoglobin (Human) | S, T | Injection | 300 ug | 2209.8 | 1st | 1670 | 14.06.2013 | -- | 19.28% | -- |
||
-- |
Polyvalent Antisnake Venom | P,S,T | Injection | 10ml | 410.56 | 5th | 2251 | 22.07.2013 | -- | 14.01% | -- |
||
-- |
Diphtheria Antitoxin | S.T | Injection | 10000 IU | 1156 | -- |
4.46% | -- |
|||||
-- |
Rabies Immunoglobin | P,S,T | Injection | 150 IU/ml | 1255.84 | -- |
48.33% | -- |
|||||
-- |
Average % Reduction | -- | 21.52% | -- |
|||||||||
-- |
Therefore, PTR per unit | 1523.81 X (1-21.52%) | 1195.89 | -- |
|||||||||
-- |
Add: 16% Retailer Margin | -- | 191.34 | -- |
|||||||||
-- |
Ceiling Price per unit | -- | 1387.23 | -- |
|||||||||
-- |
S.O. 3372(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | NLEM 2011 with Isomer final | Company | Brands | Pack Description | Dosage Form | Pack Size | Unit | PTR / Strip | MAT Value as on 31st May 2012 | MAT % | PTR per tablet | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 20.2.1.1 | Neostigmine 15mg tablets | Tablets (India) Ltd. | Tilstigmin | NA | Tablet | 10 | Strip | 67.57 | 4500000 | 100% | 6.76 | -- |
-- |
4500000 | 100% | -- |
||||||||||
-- |
Monopoly situation as M/s Tablets (India) Ltd. is the only company manufacturing the formulation and has market share of 100% | -- |
|||||||||||
-- |
PTR per tablet | -- | 6.76 | -- |
|||||||||
-- |
Price fixed in the relevant sub-section for other drugs is as follows: | -- |
|||||||||||
-- |
Medicines | Category | Route of Admn | Strength | MRP excl. local taxes (Rs./unit) | Meeting No. | S.O No | Date | – | % Reduction w.r.t. Highest Price | -- |
||
| -- | 20.2.2.2 | Neostigmine | S, T | Injection | 0.5mg/ml | 4.04 | 1st | 1675 | 14.06.2013 | -- | 40.93% | -- |
|
-- |
Therefore, PTR per unit | 6.76 X (1-40.93%) | 3.99 | -- |
|||||||||
-- |
Add: 16% Retailer Margin | -- | 0.64 | -- |
|||||||||
-- |
Ceiling Price per unit | -- | 4.63 | -- |
|||||||||
-- |
S.O. 3373(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 21.4.2.1 | Betaxolol Hydrochloride Drops 0.25% | CIPLA | OPTIPRES-S | OPTIPRES-S EYE DROPS 0.25 % 5 ML x 1 | Opthal Liquid | 5 | ML | 24.05 | 227334 | 100.0% | 4.81 |
-- |
227334 | 100.0% | 4.81 | |||||||||
-- |
Average Price | 4.81 | -- |
|||||||||
-- |
% reduction to the highest price | -- | 0 | -- |
||||||||
-- |
Thus, it is a monopoly case since there are less than 5 manufacturers & insignificant reduction is observed as compared to the highest priced pack | -- |
||||||||||
-- |
PTR per unit as per IMS Health data | -- | NA | -- |
||||||||
-- |
Prices fixed in the relevant sub -section is as follows: | -- |
||||||||||
-- |
21.4: Miotics and Antiglucoma medicines | -- |
||||||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | -- |
|||
-- |
Acetazolamide | S, T | Tablets | 250mg | 3.69 | 2nd | 1816 (E) dt 21.06.13 | 42.55 | -- |
|||
-- |
Betaxolol Hydrochloride | T | Drops | 0.0025 | -- |
|||||||
-- |
Betaxolol Hydrochloride | T | Injection | 0.005 | 6.59 | 1st | 1677 (E) dt 14.06.13 | 15.05 | -- |
|||
-- |
Pilocarpine | S, T | Drops | 0.02 | 9.9 | 7th | 2862 (E) dt 20.09.13 | 6.66 | -- |
|||
-- |
Pilocarpine | S, T | Drops | 0.04 | -- |
|||||||
-- |
Timolol Maleate | P, S, T | Drops | 0.0025 | 4.46 | 5th | 2252 (E) dt 22.07.13 | 24.28 | -- |
|||
-- |
Timolol Maleate | P, S, T | Drops | 0.005 | 12.07 | 5th | 2253 (E) dt 22.07.13 | 54.36 | -- |
|||
-- |
Average Reduction | -- |
28.58 | -- |
||||||||
-- |
Therfore,per unit price as per Para 6(ii) of DPCO,2013 | -- | 4.81*(1-28.58%) | 3.44 | -- |
|||||||
-- |
Add margin 16% | -- |
0.55 | -- |
||||||||
-- |
Ceiling Price | -- |
3.99 | -- |
||||||||
-- |
S.O. 3374(E) dated 05.11.2013 | -- |
||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 22.2.1.2 | Terbutaline Sulphate Injection 0.5 mg/ml | ASTRAZENECA | BRICANYL | BRICANYL INJ AMP 0.50 MG 1 ML x 1 (/1ML) | Ampoules | 1 | ML | 9.52 | 3500258 | 100.0% |
-- |
3500258 | 100.0% | |||||||||
-- |
Average Price | 9.52 | -- |
||||||||
-- |
Thus, it is a monopoly case since there are less than 5 manufacturers & insignificant reduction is observed as compared to the highest priced pack | -- |
|||||||||
-- |
PTR per unit as per IMS Health data | -- | NA | -- |
|||||||
-- |
Prices fixed in the relevant sub -section is as follows: | -- |
|||||||||
-- |
20 Muscle Relaxants (Peripherally acting) and Choolonesterase Inhibitors | -- |
|||||||||
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | Ceiling price | Meeting No. | S.O. No. & Date | % reduction to Highest price pack | -- |
||
-- |
Terbutaline Sulphate | S, T | Tablets | 2.5mg | 0.98 | 1st meeting | 1682(E) dt 14.06.2013 | 24.66 | -- |
||
-- |
Terbutaline Sulphate | S, T | Injection | 0.5mg/ml | -- |
||||||
-- |
Nifedipine | S, T | Tablets | 10mg | 1.13 | 1st meeting | 1638(E) dt 14.06.2013 | 16.96 | -- |
||
-- |
Betamethasone | P,S, T | Injection | 4mg/ml | -- |
||||||
-- |
Average Reduction | -- |
20.81 | -- |
|||||||
-- |
Therfore,per unit price as per Para 6(ii) of DPCO,2013 | -- |
9.52*(1-20.81%) | 7.54 | -- |
||||||
-- |
Add margin 16% | -- |
1.21 | -- |
|||||||
-- |
Ceiling Price | -- |
8.75 | -- |
|||||||
-- |
S.O. 3375(E) dated 05.11.2013 | -- |
|||||||||
| Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit |
| 1.2.2.2 | Lignocaine Hydrocloride Injection 1% | Sunways(India) | Occulan Inj. | Lignocaine Hydrocloride Injection 1% | Ampoule | 1 | 11.71 | 1925000 | 100.00% | 11.71 |
-- |
Monopoly situation as only M/s. Sunways(India) is the known manufacturer | -- | -- | -- |
-- | -- | -- | -- | ||
-- |
PTR per unit | 11.71 | -- | -- |
-- | -- | -- | -- | ||
-- |
Price fixed in the relevant sub-section for other drugs is as follows: | -- | -- | -- |
-- | -- | -- | -- | ||
| 12.2: Antiarrhythmic medicines | -- |
-- | ||||||||
| -- | Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- | -- |
-- | |||
| 1 | Lignocaine Hydrochloride | S, T | Injection | 1% | -- | -- |
-- | |||
| 2 | Lignocaine Hydrochloride | S, T | Injection | 2% | 1.00/ml | 5th meeting | 2248 | 22.07.2013 | 49.41% | -- |
-- |
-- |
-- | -- | -- | -- | |||||
| -- | Therefore, PTR per unit | 11.71 X (1-49.41%) | 5.92 | -- | -- |
-- | -- | -- | -- | |
| -- | Add: 16% Retailer Margin | -- | 0.95 | -- | -- |
-- | -- | -- | -- | |
| -- | Ceiling Price per unit | -- | 6.87 | -- | -- |
-- | -- | -- | -- | |
-- |
S.O. 3376(E) dated 05.11.2013 | -- |
||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 21.1.6.1 | Sulphacetamide Sodium Drops 10% | ALLERGAN | ALBUCID | ALBUCID EYE DROPS 10 % 10 ML x 1 | Drops | 10 | ML | 18.06 | 2514577 | 26.37% | 1.81 | -- |
| -- | 21.1.6.1 | Sulphacetamide Sodium Drops 10% | EAST INDIA | LOCULA | LOCULA EYE DROPS 10 % 10 ML x 1 | Drops | 10 | ML | 21.75 | 7020346 | 73.63% | 2.17 | -- |
| -- | 21.1.6.1 | Sulphacetamide Sodium Drops 10% | INDOCO | TOPCULA | TOPCULA EYE DROPS 10 % 10 ML x 1 | Drops | 10 | ML | 9.53 | 343 | 0.00% | 0.95 | -- |
-- |
9535266 | 100.00% | 1.99 | 2.31 | |||||||||
-- |
maximum | 2.17 | minimum | 1.81 | |||||||||
-- |
As per the above there are 2 companies consisting of Market Share of 1% & Above | -- |
|||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
95.35 | (Rs. In Lakhs) | -- |
||||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
3.98 | -- |
|||||||||
-- |
Number of Packs considered | -- |
2 | -- |
|||||||||
-- |
Ceiling Price | -- |
1.99 | -- |
|||||||||
-- |
Add : 16% Retailer Margin | -- |
0.32 | -- |
|||||||||
-- |
MRP (without local taxes) | -- |
2.31 | -- |
|||||||||
-- |
% Reduction with compared to Highest Price | -- |
8.27% | -- |
|||||||||
-- |
S.O. 3377(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brands | Pack Description | Dosage Form | Pack Size | ML | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 21.1.6.2 | Sulphacetamide Sodium Drops 20% | ALLERGAN | ALBUCID | ALBUCID EYE DROPS 20 % 10 ML x 1 | Drops | 10 | ML | 18.17 | 6978320 | 24.27% | 1.82 | -- |
| -- | 21.1.6.2 | Sulphacetamide Sodium Drops 20% | INTAS PHARMA* | ANDREMIDE | ANDREMIDE EYE DROPS 20 % 10 ML x 1 | Drops | 10 | ML | 16.98 | 1288241 | 4.48% | 1.70 | -- |
| -- | 21.1.6.2 | Sulphacetamide Sodium Drops 20% | EAST INDIA | LOCULA | LOCULA EYE DROPS 20 % 10 ML x 1 | Drops | 10 | ML | 25.21 | 20213949 | 70.31% | 2.52 | -- |
| -- | 21.1.6.2 | Sulphacetamide Sodium Drops 20% | JAWA | SULPHACID PLUS | SULPHACID PLUS EYE DROPS 20 % 7 ML x 1 | Drops | 7 | ML | 10.99 | 31332 | 0.11% | 1.57 | -- |
| -- | 21.1.6.2 | Sulphacetamide Sodium Drops 20% | JAWA | SULPHACID PLUS | SULPHACID PLUS EYE DROPS 20 % 10 ML x 1 | Drops | 10 | ML | 10.99 | 238877 | 0.83% | 1.10 | -- |
-- |
28750719 | 100.00% | 2.01 | 2.33 | |||||||||
-- |
maximum | 2.52 | minimum | 1.70 | |||||||||
-- |
As per the above there are 3 companies consisting of Market Share of 1% & Above | -- |
|||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
284.81 | (Rs. In Lakhs) | -- |
||||||||
-- |
Sum of PTR per unit considered for price calculation | -- |
6.04 | -- |
|||||||||
-- |
Number of Packs considered | -- |
3 | -- |
|||||||||
-- |
Ceiling Price | -- |
2.01 | -- |
|||||||||
-- |
Add : 16% Retailer Margin | -- |
0.32 | -- |
|||||||||
-- |
MRP (without local taxes) | -- |
2.33 | -- |
|||||||||
-- |
% Reduction with compared to Highest Price | -- |
20.19% | -- |
|||||||||
-- |
S.O. 3378(E) dated 05.11.2013 | -- |
|||||||||||
| S.No. | Unique No. as per NLEM | Composition as per NLEM | Company | Brand | Pack Description | Dosage Form | Pack Size | Unit | Price to Retailer | MAT Value as on 31st May 2012 | MAT % | Price per Unit | Ceiling Price with 16% Margin | Price per Unit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ALEMBIC | AZITHRAL | AZITHRAL FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 70.48 | 752510555 | 25.21% | 23.49 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CIPLA | AZEE | AZEE FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 54.10 | 278316451 | 9.32% | 18.03 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | WOCKHARDT LTD* | AZIWOK | AZIWOK FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 79.60 | 143879619 | 4.82% | 26.53 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | FDC | ZATHRIN | ZATHRIN FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 46.11 | 125513122 | 4.20% | 15.37 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | IPCA LABS | AZIBACT | AZIBACT FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 59.96 | 94671078 | 3.17% | 19.99 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | IPCA LABS | AZIBACT | AZIBACT FILM C.TABS 500 MG x 5 | Tablets | 5 | Per Tabs/caps | 88.38 | 3250331 | 0.11% | 17.68 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | RANBAXY* | AZAX | AZAX FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 47.02 | 90031900 | 3.02% | 15.67 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MANKIND | ZADY | ZADY FILM C.TABS 500 MG x 6 | Tablets | 6 | Per Tabs/caps | 71.54 | 30045672 | 1.01% | 11.92 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MANKIND | ZADY | ZADY FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 41.90 | 55893004 | 1.87% | 13.97 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | INDOCO* | ATM | ATM FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 62.10 | 83079023 | 2.78% | 20.70 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CIPLA | AZIMAX | AZIMAX FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 54.10 | 83037225 | 2.78% | 18.03 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | HETERO HEALTHCARE* | LAZ | LAZ FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 33.37 | 72701792 | 2.44% | 11.12 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MACLEODS PHARMA | ZITHROX | ZITHROX FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 53.73 | 70956052 | 2.38% | 17.91 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MICRO LABS* | AZILIDE | AZILIDE FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 59.23 | 69079333 | 2.31% | 19.74 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | PFIZER* | TRULIMAX | TRULIMAX FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 65.95 | 63815657 | 2.14% | 21.98 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ZYDUS CADILA* | ZITHROCIN | ZITHROCIN FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 46.07 | 56464228 | 1.89% | 15.36 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CIPLA | AZIPRO | AZIPRO FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 54.10 | 50386360 | 1.69% | 18.03 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ARISTO PHARMA* | AZIVENT | AZIVENT FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 38.42 | 48445423 | 1.62% | 12.81 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | BLUE CROSS | AZIBEST | AZIBEST FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 45.35 | 41825990 | 1.40% | 15.12 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ALKEM* | PRATHAM | PRATHAM FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 47.24 | 41761276 | 1.40% | 15.75 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ABBOTT* | ERTYCIN | ERTYCIN FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 33.34 | 39037924 | 1.31% | 11.11 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | GLENMARK PHARMA | AZIFINE + | AZIFINE + FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 52.00 | 38606660 | 1.29% | 17.33 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ABBOTT* | AZRO | AZRO FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 41.48 | 36105949 | 1.21% | 13.83 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ALEMBIC | AZITHRAL-SI | AZITHRAL-SI FILM C.TABS 500 MG x 5 | Tablets | 5 | Per Tabs/caps | 154.78 | 33482466 | 1.12% | 30.96 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ALBERT DAVID | AZ3 | AZ3 FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 62.54 | 29214305 | 0.98% | 20.85 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | IPCA LABS | AZIFAST | AZIFAST FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 54.86 | 27584174 | 0.92% | 18.29 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | UNISON PHARMA | UTHRAL | UTHRAL TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 38.20 | 26529800 | 0.89% | 12.73 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ALKEM* | ZITHIUM | ZITHIUM TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 40.30 | 24854633 | 0.83% | 13.43 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ALKEM* | AZIKEM | AZIKEM TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 30.52 | 23204126 | 0.78% | 10.17 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MICRO LABS* | AZIWIN | AZIWIN FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 55.69 | 21522505 | 0.72% | 18.56 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | EMCURE* | AZITUS | AZITUS FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 49.23 | 20306479 | 0.68% | 16.41 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | TORRENT PHARMA | MACROTOR | MACROTOR FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 55.38 | 19955104 | 0.67% | 18.46 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | INDI PHARMA | AZID | AZID FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 49.50 | 18284179 | 0.61% | 16.50 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | INDI PHARMA | AZID | AZID CAPS 500 MG x 3 | Capsules | 3 | Per Tabs/caps | 50.08 | 1239280 | 0.04% | 16.69 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | SANOFI* | RULIDE-AZ | RULIDE-AZ FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 58.46 | 19306578 | 0.65% | 19.49 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | AMBALAL SARABHAI | AZEE | AZEE FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 89.93 | 16348829 | 0.55% | 29.98 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | BESTOCHEM | AZIBIG | AZIBIG FILM C.TABS 500 MG x 10 | Tablets | 10 | Per Tabs/caps | 40.00 | 1104238 | 0.04% | 4.00 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | BESTOCHEM | AZIBIG | AZIBIG FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 52.32 | 13864582 | 0.46% | 17.44 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | KHANDELWAL | AZINIX | AZINIX FILM C.TABS 500 MG x 6 | Tablets | 6 | Per Tabs/caps | 63.75 | 13891304 | 0.47% | 10.63 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MSD PHARMACEUTICAL | AZUMA | AZUMA FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 63.98 | 11384068 | 0.38% | 21.33 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CFL | AVINDO | AVINDO FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 55.55 | 11064401 | 0.37% | 18.52 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CIPLA | AZICIP | AZICIP FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 35.26 | 10882201 | 0.36% | 11.75 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | LUPIN LIMITED | AZISWIFT | AZISWIFT FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 64.00 | 10827907 | 0.36% | 21.33 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | INTAS PHARMA* | ZEETHROM | ZEETHROM FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 36.34 | 10656336 | 0.36% | 12.11 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | SHINE PHARMA | ZOFACIN | ZOFACIN TABS 500 MG x 10 | Tablets | 10 | Per Tabs/caps | 153.86 | 10070750 | 0.34% | 15.39 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | PANACEA BIOTEC | VALUETHRAL | VALUETHRAL TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 44.95 | 9893202 | 0.33% | 14.98 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | UCB PHARMA | MAXITHRAL | MAXITHRAL FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 64.76 | 9801713 | 0.33% | 21.59 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MOLEKULE INDIA | AZIPAR | AZIPAR FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 69.76 | 8485117 | 0.28% | 23.25 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | PHARMED | SUPRAZI | SUPRAZI FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 45.38 | 7841443 | 0.26% | 15.13 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | LUPIN LIMITED | Z-1 | Z-1 FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 57.21 | 7763119 | 0.26% | 19.07 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | OVERSEAS | AZYSAFE | AZYSAFE FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 49.80 | 7557794 | 0.25% | 16.60 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | RPG LIFE SCIENCES | AZISTART | AZISTART FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 49.52 | 7389054 | 0.25% | 16.51 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MANEESH PHARMA* | ZETORIN | ZETORIN FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 40.77 | 6272558 | 0.21% | 13.59 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | JAGSON PAL | ROWEZY | ROWEZY TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 55.41 | 6172690 | 0.21% | 18.47 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | RELIANCE | 3A | 3A FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 81.75 | 6139671 | 0.21% | 27.25 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | PSYCHOTROPICS | AZITOP | AZITOP FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 44.15 | 6126162 | 0.21% | 14.72 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CADILA PHARMA | AZIVISTA | AZIVISTA TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 33.00 | 5809806 | 0.19% | 11.00 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | PFIZER* | VICON | VICON FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 65.95 | 5626920 | 0.19% | 21.98 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MEYER ORGANICS | ZITHROCARE | ZITHROCARE FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 50.64 | 5558777 | 0.19% | 16.88 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | LUPIN LIMITED | AZILUP | AZILUP FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 59.23 | 5193516 | 0.17% | 19.74 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | RANBAXY* | TAZIX | TAZIX FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 48.46 | 5090049 | 0.17% | 16.15 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ALKEM* | CAZITHRO | CAZITHRO TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 48.00 | 4864677 | 0.16% | 16.00 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | IND-SWIFT | AZOVID | AZOVID TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 81.75 | 4768562 | 0.16% | 27.25 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | LEBEN LABS | AZILEB | AZILEB TABS 500 MG x 6 | Tablets | 6 | Per Tabs/caps | 72.87 | 4508392 | 0.15% | 12.14 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CADILA PHARMA | ZYCIN | ZYCIN CAPS 500 MG x 3 | Capsules | 3 | Per Tabs/caps | 63.23 | 3925405 | 0.13% | 21.08 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CADILA PHARMA | ZYCIN | ZYCIN FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 57.94 | 557730 | 0.02% | 19.31 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | PALSON DRUG | Q-AZI | Q-AZI FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 56.53 | 4047657 | 0.14% | 18.84 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | RPG LIFE SCIENCES | AZIPHAR | AZIPHAR FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 69.49 | 4004510 | 0.13% | 23.16 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | SKYMAX LABS | AZIDAY | AZIDAY TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 59.95 | 3903466 | 0.13% | 19.98 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | UNICHEM* | AZFORIN | AZFORIN TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 45.26 | 3737949 | 0.13% | 15.09 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | DABUR | AZIFEM | AZIFEM FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 45.77 | 3728012 | 0.12% | 15.26 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | GUJARAT TERCE | AZITER | AZITER FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 39.23 | 3434784 | 0.12% | 13.08 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | GUJARAT TERCE | AZITER | AZITER FILM C.TABS 500 MG x 6 | Tablets | 6 | Per Tabs/caps | 92.50 | 197580 | 0.01% | 15.42 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | IND-SWIFT | AZITHRO | AZITHRO FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 42.69 | 3567871 | 0.12% | 14.23 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | APEX | AZICLASS | AZICLASS TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 50.90 | 3481659 | 0.12% | 16.97 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | KOPRAN | AZ-1 | AZ-1 CAPS 500 MG x 3 | Capsules | 3 | Per Tabs/caps | 41.51 | 3479412 | 0.12% | 13.84 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | TROIKAA PHARMA | AZITROY | AZITROY FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 52.89 | 3432661 | 0.11% | 17.63 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MEDLEY PHARMA | AZIRITE | AZIRITE TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 46.03 | 3354991 | 0.11% | 15.34 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | DR REDDYS LABS | AZORTA | AZORTA FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 65.38 | 3317629 | 0.11% | 21.79 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | AGIO PHARMA | AZIAGIO | AZIAGIO FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 43.43 | 3271574 | 0.11% | 14.48 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | WALLACE | ZIWAL | ZIWAL TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 67.75 | 3269758.5 | 0.11% | 22.58 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CORONA REMEDIES | XITH | XITH TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 32.38 | 3191151 | 0.11% | 10.79 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CIPLA | AZEEMUNE | AZEEMUNE FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 49.77 | 3175127 | 0.11% | 16.59 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ORCHID CHEM&PHARM* | MACROAZI | MACROAZI TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 46.15 | 3099572 | 0.10% | 15.38 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | LEO PHARMA | AZIGOLD | AZIGOLD TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 45.81 | 2851259 | 0.10% | 15.27 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | HELIOS | RONIN | RONIN FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 44.95 | 2581521 | 0.09% | 14.98 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | LINCOLN PHARMA | AZILIN | AZILIN TABS 500 MG x 6 | Tablets | 6 | Per Tabs/caps | 102.43 | 2544462 | 0.09% | 17.07 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | FLAMINGO PHARMA | FLAAG | FLAAG TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 44.73 | 2515747 | 0.08% | 14.91 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | THEMIS MEDICARE | AZAD | AZAD FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 30.00 | 2211270 | 0.07% | 10.00 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MEDICO LABS | AZIMED | AZIMED FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 51.20 | 1970279 | 0.07% | 17.07 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ELDER PHARMA | ELZEE | ELZEE TAB UNCOATED 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 36.55 | 1829644 | 0.06% | 12.18 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | NULIFE | NUAZY | NUAZY FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 57.35 | 1697273 | 0.06% | 19.12 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | SUNIJ PHARMA | AZINIJ | AZINIJ FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 29.34 | 1625643 | 0.05% | 9.78 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | GUFIC | AZNEE | AZNEE FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 46.13 | 1585537 | 0.05% | 15.38 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | INVIDA INDIA | AZCRE | AZCRE TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 67.58 | 1506764 | 0.05% | 22.53 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | KARNATAKA ANTIBIOT | VERZIT | VERZIT FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 49.05 | 1452521 | 0.05% | 16.35 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | TWILIGHT MARCANTIL | LITAZITH | LITAZITH TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 50.14 | 1363909 | 0.05% | 16.71 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CIPLA | AZIMED | AZIMED FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 62.51 | 1267953 | 0.04% | 20.84 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | INTAS PHARMA* | AZITAB | AZITAB TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 76.00 | 1252555 | 0.04% | 25.33 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | YASH PHARMA | YASH-ZI | YASH-ZI FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 31.45 | 1178273 | 0.04% | 10.48 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MEDO PHARMA | ORTIZA | ORTIZA FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 56.82 | 1070317 | 0.04% | 18.94 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | GROUP | AZOO | AZOO FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 69.36 | 1063081 | 0.04% | 23.12 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | INTAS PHARMA* | AZITAS | AZITAS TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 26.00 | 1054194 | 0.04% | 8.67 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CIPLA | ZOMYCIN | ZOMYCIN TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 34.50 | 1019096 | 0.03% | 11.50 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | AR EX | SAF-AZ | SAF-AZ FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 53.85 | 1015019 | 0.03% | 17.95 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | REKVINA | MIOMYCIN | MIOMYCIN TABS 500 MG x 6 | Tablets | 6 | Per Tabs/caps | 223.67 | 957084 | 0.03% | 37.28 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | GOLDLINE PHARMACE. | AZITHREE | AZITHREE FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 67.45 | 934451 | 0.03% | 22.48 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | HELIOS | AZITHROX | AZITHROX FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 69.89 | 930305 | 0.03% | 23.30 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | IND-SWIFT | AZOMAX | AZOMAX FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 53.14 | 925113 | 0.03% | 17.71 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | NOVARTIS INTL.* | LOROMYCIN | LOROMYCIN CAPS 500 MG x 3 | Capsules | 3 | Per Tabs/caps | 55.50 | 913452 | 0.03% | 18.50 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | STERKEM | AZIMON | AZIMON FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 44.96 | 866065 | 0.03% | 14.99 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | EAST INDIA | REMYCINE | REMYCINE FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 66.16 | 770065 | 0.03% | 22.05 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ZYDUS CADILA* | AZIDUS | AZIDUS TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 67.32 | 767179 | 0.03% | 22.44 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | AGLOWMED | AZIPOS | AZIPOS FILM C.TABS 500 MG x 6 | Tablets | 6 | Per Tabs/caps | 89.15 | 709367 | 0.02% | 14.86 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | INDICA | AZINDICA | AZINDICA FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 38.09 | 696858 | 0.02% | 12.70 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ABBOTT* | AZISARA | AZISARA TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 118.13 | 689761 | 0.02% | 39.38 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MANKIND | AZIGARD | AZIGARD TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 32.16 | 629115 | 0.02% | 10.72 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | IND-SWIFT | SWITHRO | SWITHRO FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 36.79 | 622081 | 0.02% | 12.26 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | OCHOA LAB | AZAR | AZAR FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 53.08 | 595983 | 0.02% | 17.69 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | UNICHEM* | AZEM | AZEM TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 39.24 | 555717 | 0.02% | 13.08 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MARC LABORATORIES | AZOMARC | AZOMARC FILM C.TABS 500 MG x 10 | Tablets | 10 | Per Tabs/caps | 148.50 | 543658 | 0.02% | 14.85 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | UNIQUE PHARM | AZICYTE | AZICYTE FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 50.29 | 461565 | 0.02% | 16.76 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | TORRENT PHARMA | AZISUPER | AZISUPER FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 34.62 | 442340 | 0.01% | 11.50 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | SATVEN&MER PHARMA | VENTROX-DS | VENTROX-DS TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 69.49 | 441749 | 0.01% | 23.16 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MOREPEN LABS | AZENAS | AZENAS TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 71.94 | 412432 | 0.01% | 23.98 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MEDLEY PHARMA | AZY | AZY FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 24.00 | 389641 | 0.01% | 8.00 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | THEMIS PHARMA | DEFTOLIDE | DEFTOLIDE FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 55.89 | 386591 | 0.01% | 18.63 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | AKESISS PHARMA | AZITSA | AZITSA FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 53.06 | 314647 | 0.01% | 17.69 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MOREPEN LABS | AZIDOC | AZIDOC TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 76.03 | 243372 | 0.01% | 25.34 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | U S V | AZOTIK | AZOTIK FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 61.33 | 222628 | 0.01% | 20.44 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | OMEGA REMEDIES | AGEE | AGEE FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 61.83 | 220531 | 0.01% | 20.61 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | NAVIL | NAZITH | NAZITH FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 57.75 | 212231 | 0.01% | 19.25 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | MERCURY LABS | AZIMER | AZIMER FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 49.05 | 171577 | 0.01% | 16.35 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | LUPIN LIMITED | OZICIN | OZICIN TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 29.22 | 167928 | 0.01% | 9.74 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | SYSMED LAB | SYSTHRAL | SYSTHRAL FILM C.TABS 500 MG x 10 | Tablets | 10 | Per Tabs/caps | 37.66 | 156477 | 0.01% | 3.77 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | SEAGULL LABS | AZIMACRO | AZIMACRO TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 61.55 | 124700 | 0.00% | 20.52 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | WISDOM PHARMA | AZIWIS | AZIWIS FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 42.54 | 116943 | 0.00% | 14.18 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | REMEX PHARMA | AZIKEM | AZIKEM FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 56.41 | 103456 | 0.00% | 18.80 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | SAMARTH PHARMA | PLUGCIN | PLUGCIN FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 56.41 | 44338 | 0.00% | 18.80 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ZEE LABS | AZITH | AZITH FILM C.TABS 500 MG x 10 | Tablets | 10 | Per Tabs/caps | 163.11 | 35721 | 0.00% | 16.31 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ELDER PHARMA | ONAZIT | ONAZIT FILM C.TABS 500 MG x 10 | Tablets | 10 | Per Tabs/caps | 147.15 | 22955 | 0.00% | 14.71 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ALKEM* | MEGAMAC | MEGAMAC FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 44.93 | 22824 | 0.00% | 14.98 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | GLAXOSMITHKLINE* | AZERIKA | AZERIKA TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 44.93 | 4852 | 0.00% | 14.98 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | ALEMBIC | GERIMAC | GERIMAC FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 65.38 | 2550 | 0.00% | 21.81 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | SEAGULL LABS | AZO | AZO TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 49.06 | 2502 | 0.00% | 16.35 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | LUPIN LIMITED | AZIPLUS | AZIPLUS FILM C.TABS 500 MG x 10 | Tablets | 10 | Per Tabs/caps | 61.32 | 1717 | 0.00% | 6.13 | -- | -- |
| -- | 6.2.12.3 | Azithromycin Tablets 500mg | CENTAUR | ZIOX | ZIOX FILM C.TABS 500 MG x 3 | Tablets | 3 | Per Tabs/caps | 48.86 | 1710 | 0.00% | 16.29 | -- | -- |
-- |
2.986E+09 | 100.00% | 17.68 | 20.51 | Price with 16% | |||||||||
-- |
maximum | 39.38 | minimum | 10.17 | -- | |||||||||
-- |
Data consisting of Market Share of 1% & Above | -- |
||||||||||||
-- |
Sum of MAT value considered for price calculation | -- |
25341.00 | (Rs. In Lakhs) | -- |
|||||||||
-- |
Sum of PTR considered for price calculation | -- |
707.03 | -- |
||||||||||
-- |
Number of Packs considered | -- |
40 | -- |
||||||||||
-- |
Ceiling Price | -- |
17.68 | -- |
||||||||||
-- |
Add : 16% Retailer Margin | -- |
2.83 | -- |
||||||||||
-- |
MRP (without local taxes) | -- |
20.51 | -- |
||||||||||
-- |
% Reduction with compared to Highest Price | -- |
55.10% | -- |
||||||||||
-- |
S.O. 3379(E) dated 05.11.2013 | -- |
||||||||||||
Last Page Updated: 22-01-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)